Donate now
EN FR

Genomic Epidemiology Branch (GEM)

Publications

All recent publications: 2024-2020

 

  1. Zahed, H., Feng, X., Sheikh, M., Bray, F., Ferlay, J., Ginsburg, O., . . . Robbins, H. A. (2024). Age at diagnosis for lung, colon, breast and prostate cancers: An international comparative study. International Journal of Cancer. 154(1): 28-40. PMID: 37615573 https://doi.org/10.1002/ijc.34671           
  2. Alcala, K., Poustchi, H., Viallon, V., Islami, F., Pourshams, A., Sadjadi, A., . . . Sheikh, M. (2023). Incident cancers attributable to using opium and smoking cigarettes in the Golestan cohort study. EClinicalMedicine. 64: 102229. PMID: 37781157 https://doi.org/10.1016/j.eclinm.2023.102229   
  3. Alcala, K., Zahed, H., Cortez Cardoso Penha, R., Alcala, N., Robbins, H. A., Smith-Byrne, K., . . . Johansson, M. (2023). Kidney Function and Risk of Renal Cell Carcinoma. Cancer Epidemiology, Biomarkers and Prevention. 32(11): 1644-1650. PMID: 37668600 https://doi.org/10.1158/1055-9965.Epi-23-0558              
  4. Alcala, N., & Fernandez-Cuesta, L. A. (2023). Lifting the curtain on molecular differences between malignant pleural mesotheliomas. Nature Genetics. 55(4): 540-541. PMID: 36928604 https://doi.org/10.1038/s41588-023-01322-0              
  5. Arboleda, L. P. A., de Carvalho, G. B., Santos-Silva, A. R., Fernandes, G. A., Vartanian, J. G., Conway, D. I., . . . Curado, M. P. (2023). Squamous Cell Carcinoma of the Oral Cavity, Oropharynx, and Larynx: A Scoping Review of Treatment Guidelines Worldwide. Cancers. 15(17). PMID: 37686681 https://doi.org/10.3390/cancers15174405       
  6. Arboleda, L. P. A., Neves, A. B., Kohler, H. F., Vartanian, J. G., Candelaria, L. M., Borges, M. F., . . . Curado, M. P. (2023). Overview of glottic laryngeal cancer treatment recommendation changes in the NCCN guidelines from 2011 to 2022. Cancer Rep (Hoboken). 6(8): e1837. PMID: 37288471 https://doi.org/10.1002/cnr2.1837      
  7. Berndt, S. I., Vijai, J., Benavente, Y., Camp, N. J., Nieters, A., Wang, Z., . . . Rothman, N. (2023). Correction: Distinct germline genetic susceptibility profiles identified for common non-Hodgkin lymphoma subtypes. Leukemia. 37(10): 2142-2142. PMID: 37666943 https://doi.org/10.1038/s41375-023-01978-x               
  8. Budhathoki, S., Diergaarde, B., Liu, G., Olshan, A., Ness, A., Waterboer, T., . . . Hung, R. J. (2023). A risk prediction model for head and neck cancers incorporating lifestyle factors, HPV serology and genetic markers. International Journal of Cancer. 152(10): 2069-2080. PMID: 36694401 https://doi.org/10.1002/ijc.34444
  9. Callister, M. E. J., Crosbie, E. J., Crosbie, P. A. J., & Robbins, H. A. (2023). Evaluating multi-cancer early detection tests: an argument for the outcome of recurrence-updated stage. British Journal of Cancer. 129(8): 1209-1211. PMID: 37726480 https://doi.org/10.1038/s41416-023-02434-4    
  10. Casolino, R., Johns, A. L., Courtot, M., Lawlor, R. T., De Lorenzo, F., Horgan, D., . . . Lancet Oncology Commission, C. (2023). Accelerating cancer omics and precision oncology in health care and research: a Lancet Oncology Commission. Lancet Oncology. 24(2): 123-125. PMID: 36725142 https://doi.org/10.1016/S1470-2045(23)00007-4        
  11. Cheng, C., Hong, W., Li, Y., Xiao, X., McKay, J., Han, Y., . . . Consortium, I.-I. L. C. (2023). Mosaic Chromosomal Alterations Are Associated With Increased Lung Cancer Risk: Insight From the INTEGRAL-ILCCO Cohort Analysis. Journal of Thoracic Oncology. 18(8): 1003-1016. PMID: 37150255 https://doi.org/10.1016/j.jtho.2023.05.001  
  12. Clasen, J. L., Mabunda, R., Heath, A. K., Kaaks, R., Katzke, V., Schulze, M. B., . . . Muller, D. C. (2023). Reproductive and hormonal factors and risk of renal cell carcinoma among women in the European Prospective Investigation into Cancer and Nutrition. Cancer Med. 12(14): 15588-15600. PMID: 37269199 https://doi.org/10.1002/cam4.6207               
  13. Cortez Cardoso Penha, R., Smith-Byrne, K., Atkins, J. R., Haycock, P. C., Kar, S., Codd, V., . . . McKay, J. D. (2023). Common genetic variations in telomere length genes and lung cancer: a Mendelian randomisation study and its novel application in lung tumour transcriptome. Elife. 12. PMID: 37079368 https://doi.org/10.7554/eLife.83118   
  14. Diaz-Velasquez, C. E., Gitler, R., Antoniano, A., Kershenovich Sefchovich, R., De La Cruz-Montoya, A. H., Martinez-Gregorio, H., . . . Vaca-Paniagua, F. (2023). Evaluation of genetic alterations in hereditary cancer susceptibility genes in the Ashkenazi Jewish women community of Mexico. Front Genet. 14: 1094260. PMID: 36845387 https://doi.org/10.3389/fgene.2023.1094260    
  15. D’Souza, G., Tewari, S. R., Troy, T., Waterboer, T., Struijk, L., Castillo, R., . . . Fakhry, C. (2023). Prevalence of oral and blood oncogenic human papillomavirus biomarkers among an enriched screening population: Baseline results of the MOUTH study. Cancer. 129(15): 2373-2384. PMID: 37032449 https://doi.org/10.1002/cncr.34783           
  16. Dumontet, C., Demangel, D., Galia, P., Karlin, L., Roche, L., Fauvernier, M., . . . Garderet, L. (2023). Clinical characteristics and outcome of 318 families with familial monoclonal gammopathy: A multicenter Intergroupe Francophone du Myelome study. American Journal of Hematology. 98(2): 264-271. PMID: 36588407 https://doi.org/10.1002/ajh.2678    
  17. Fares, A. F., Li, Y., Jiang, M., Brown, M. C., Lam, A. C. L., Aggarwal, R., . . . Liu, G. F. (2023). Association between duration of smoking abstinence before non-small-cell lung cancer diagnosis and survival: a retrospective, pooled analysis of cohort studies. Lancet Public Health. 8(9): E691-E700. PMID: 37633678 https://doi.org/10.1016/S2468-2667(23)00131-7             
  18. Feng, X., Muller, D. C., Zahed, H., Alcala, K., Guida, F., Smith-Byrne, K., . . . Robbins, H. A. (2023). Evaluation of pre-diagnostic blood protein measurements for predicting survival after lung cancer diagnosis. EBioMedicine. 92: 104623. PMID: 37236058 https://doi.org/10.1016/j.ebiom.2023.104623   
  19. Feng, X., Wu, W. Y., Onwuka, J. U., Haider, Z., Alcala, K., Smith-Byrne, K., . . . Johansson, M. (2023). Lung cancer risk discrimination of prediagnostic proteomics measurements compared with existing prediction tools. Journal of the National Cancer Institute. 115(9): 1050-1059. PMID: 37260165 https://doi.org/10.1093/jnci/djad071           
  20. Fernandez-Cuesta, L., Sexton-Oates, A., Bayat, L., Foll, M., Lau, S. C. M., & Leal, T. (2023). Spotlight on Small-Cell Lung Cancer and Other Lung Neuroendocrine Neoplasms. Am Soc Clin Oncol Educ Book. 43: e390794. PMID: 37229617 https://doi.org/10.1200/EDBK_390794  
  21. Garcia-Pardo, M., Chang, A., Schmid, S., Dong, M., Brown, M. C., Christiani, D., . . . Liu, G. (2023). Respiratory and Cardiometabolic Comorbidities and Stages I to III NSCLC Survival: A Pooled Analysis From the International Lung Cancer Consortium. Journal of Thoracic Oncology. 18(3): 313-323. PMID: 36396063 https://doi.org/10.1016/j.jtho.2022.10.020         
  22. Goyal, N., Hennessy, M., Lehman, E., Lin, W., Agudo, A., Ahrens, W., . . . Muscat, J. E. M. (2023). Risk factors for head and neck cancer in more and less developed countries: Analysis from the INHANCE consortium. Oral Diseases. 29(4): 1565-1578. PMID: 35322907 https://doi.org/10.1111/odi.14196    
  23. Hosseini, E., Mokhtari, Z., Poustchi, H., Khoshnia, M., Dawsey, S. M., Boffetta, P., . . . Hekmatdoost, A. (2023). Dietary Advanced Glycation End Products and Risk of Overall and Cause-Specific Mortality: Results from the Golestan Cohort Study. International Journal of Environmental Research and Public Health. 20(5): 3788. PMID: 36900799 https://doi.org/10.3390/ijerph20053788           
  24. Khodayari Moez, E., Warkentin, M. T., Brhane, Y., Lam, S., Field, J. K., Liu, G., . . . Hung, R. J. (2023). Circulating proteome for pulmonary nodule malignancy. Journal of the National Cancer Institute. 115(9): 1060-1070. PMID: 37369027 https://doi.org/10.1093/jnci/djad122    
  25. King, S. D., Veliginti, S., Brouwers, M., Ren, Z., Zheng, W., Setiawan, V. W., . . . Antwi, S. O. (2023). Genetic Susceptibility to Nonalcoholic Fatty Liver Disease and Risk for Pancreatic Cancer: Mendelian Randomization. Cancer Epidemiology, Biomarkers and Prevention. 32(9): 1265-1269. PMID: 37351909 https://doi.org/10.1158/1055-9965.EPI-23-0453           
  26. Kolijn, P. M., Späth, F., Khouja, M., Hengeveld, P. J., van der Straten, L., Darzentas, N., . . . Langerak, A. W. (2023). Genetic drivers in the natural history of chronic lymphocytic leukemia development as early as 16 years before diagnosis. Blood. 142(16): 1399-1403. PMID: 37523714 https://doi.org/10.1182/blood.2023019609         
  27. Koutros, S., Kiemeney, L. A., Pal Choudhury, P., Milne, R. L., Lopez de Maturana, E., Ye, Y., . . . Rothman, N. J. (2023). Genome-wide Association Study of Bladder Cancer Reveals New Biological and Translational Insights. European Urology. 84(1): 127-137. PMID: 37210288 https://doi.org/10.1016/j.eururo.2023.04.020              
  28. Landy, R., Gomez, I., Caverly, T. J., Kawamoto, K., Rivera, M. P., Robbins, H. A., . . . Katki, H. A. (2023). Methods for Using Race and Ethnicity in Prediction Models for Lung Cancer Screening Eligibility. Jama Network Open. 6(9): e2331155. PMID: 37721755 https://doi.org/10.1001/jamanetworkopen.2023.31155
  29. Lawrence, P., Chabane, M., Abrouk, L., Thiesson, A., Berthe, D., Diarra, A. B., . . . Gormally, E. (2023). First Molecular Characterization of Chronic Hepatitis B Carriers in Timbuktu, Mali. Diagnostics (Basel). 13(3): 375. PMID: 36766478 https://doi.org/10.3390/diagnostics13030375   
  30. Lee, R., & Robbins, H. A. (2023). PATHFINDER: another step on the uncharted path to multicancer screening. Lancet. 402(10409): 1213-1215. PMID: 37805199 https://doi.org/10.1016/S0140-6736(23)02050-0             
  31. Leyden, G. M., Greenwood, M. P., Gaborieau, V., Han, Y., Amos, C. I., Brennan, P., . . . Richardson, T. G. (2023). Disentangling the aetiological pathways between body mass index and site-specific cancer risk using tissue-partitioned Mendelian randomisation. British Journal of Cancer. 128(4): 618-625. PMID: 36434155 https://doi.org/10.1038/s41416-022-02060-6    
  32. Li, M., Park, J. Y., Sheikh, M., Kayamba, V., Rumgay, H., Jenab, M., . . . Arnold, M. (2023). Population-based investigation of common and deviating patterns of gastric cancer and oesophageal cancer incidence across populations and time. Gut. 72(5): 846-854. PMID: 36241389 https://doi.org/10.1136/gutjnl-2022-328233    
  33. Lindstrom, S., Wang, L., Feng, H., Majumdar, A., Huo, S., Macdonald, J., . . . Kraft, P. (2023). Genome-wide analyses characterize shared heritability among cancers and identify novel cancer susceptibility regions. Journal of the National Cancer Institute. 115(6): 712-732. PMID: 36929942 https://doi.org/10.1093/jnci/djad043               
  34. Lung Cancer Cohort, C. (2023). The blood proteome of imminent lung cancer diagnosis. Nat Commun. 14(1): 3042. PMID: 37264016 https://doi.org/10.1038/s41467-023-37979-8          
  35. Luyapan, J., Bossé, Y., Li, Z., Xiao, X., Rosenberger, A., Hung, R. J., . . . Amos, C. I. (2023). Candidate pathway analysis of surfactant proteins identifies CTSH and SFTA2 that influences lung cancer risk. Human Molecular Genetics. 32(18): 2842-2855. PMID: 37471639 https://doi.org/10.1093/hmg/ddad095            
  36. M Filho, A., Turner, M. C., Warnakulasuriya, S., Richardson, D. B., Hosseini, B., Kamangar, F., . . . Schubauer-Berigan, M. K. (2023). The carcinogenicity of opium consumption: a systematic review and meta-analysis. European Journal of Epidemiology. 38(4): 373-389. PMID: 36773182 https://doi.org/10.1007/s10654-023-00969-7        
  37. Mangiante, L., Alcala, N., Sexton-Oates, A., Di Genova, A., Gonzalez-Perez, A., Khandekar, A., . . . Fernandez-Cuesta, L. (2023). Multiomic analysis of malignant pleural mesothelioma identifies molecular axes and specialized tumor profiles driving intertumor heterogeneity. Nature Genetics. 55(4): 607-618. PMID: 36928603 https://doi.org/10.1038/s41588-023-01321-1    
  38. Midttun, O., Ulvik, A., Meyer, K., Zahed, H., Giles, G. G., Manjer, J., . . . Ueland, P. M. (2023). A cross-sectional study of inflammatory markers as determinants of circulating kynurenines in the Lung Cancer Cohort Consortium. Scientific Reports. 13(1): 1011. PMID: 36653422 https://doi.org/10.1038/s41598-023-28135-9  
  39. Nemati, S., Mohebbi, E., Toorang, F., Hadji, M., Hosseini, B., Saeedi, E., . . . Zendehdel, K. (2023). Population attributable proportion and number of cancer cases attributed to potentially modifiable risk factors in Iran in 2020. International Journal of Cancer. 153(10): 1758-1765. PMID: 37548110 https://doi.org/10.1002/ijc.34659               
  40. Nemati, S., Naji, P., Abdi, S., Lotfi, F., Saeedi, E., Mehravar, S. A., . . . Zendehdel, K. (2023). National and Regional Fraction of Cancer Incidence and Death Attributable to Current Tobacco and Water-Pipe Smoking in the Eastern Mediterranean Countries in 2020. Nicotine Tob Res. 25(1): 12-18. PMID: 35895382 https://doi.org/10.1093/ntr/ntac179     
  41. Nemati, S., Saeedi, E., Lotfi, F., Nahvijou, A., Pirnejad, H., Cheraghi, M., . . . Zendehdel, K. (2023). Regional disparities in cancer survival in Iran: Insight from a National Surveillance of Cancer Survival in Iran (IRANCANSURV). Cancer Epidemiology. 85: 102378. PMID: 37229955 https://doi.org/10.1016/j.canep.2023.102378
  42. Nost, T. H., Skogholt, A. H., Urbarova, I., Mjelle, R., Paulsen, E. E., Donnem, T., . . . Saetrom, P. (2023). Increased levels of microRNA-320 in blood serum and plasma is associated with imminent and advanced lung cancer. Molecular Oncology. 17(2): 312-327. PMID: 36337027 https://doi.org/10.1002/1878-0261.13336        
  43. Papadimitriou, N., Bull, C. J., Jenab, M., Hughes, D. J., Bell, J. A., Sanderson, E., . . . Murphy, N. (2023). Separating the effects of early and later life adiposity on colorectal cancer risk: a Mendelian randomization study. BMC Medicine. 21(1): 5. PMID: 36600297 https://doi.org/10.1186/s12916-022-02702-9    
  44. Perim Galvao De Podesta, O., Salaroli, L. B., Cattafesta, M., Peres, S. V., De Podesta, J. R. V., von Zeidler, S. L. V., . . . Curado, M. P. (2023). Changes in Body Mass Index Are Associated with Squamous Cell Carcinomas of Oral Cavity, Oropharynx and Larynx: A Case-Control Study in Brazil. Nutrition and Cancer. 75(2): 599-609. PMID: 36426640 https://doi.org/10.1080/01635581.2022.2143535           
  45. Rashidian, H., Hadji, M., Gholipour, M., Naghibzadeh-Tahami, A., Marzban, M., Mohebbi, E., . . . Zendehdel, K. (2023). Opium use and risk of lung cancer: A multicenter case-control study in Iran. International Journal of Cancer. 152(2): 203-213. PMID: 36043555 https://doi.org/10.1002/ijc.34244      
  46. Robbins, H. A., Alcala, K., Moez, E. K., Guida, F., Thomas, S., Zahed, H., . . . Hung, R. J. (2023). Design and methodological considerations for biomarker discovery and validation in the Integrative Analysis of Lung Cancer Etiology and Risk (INTEGRAL) Program. Annals of Epidemiology. 77: 1-12. PMID: 36404465 https://doi.org/10.1016/j.annepidem.2022.10.014          
  47. Rogers, M., Gill, D., Ahlqvist, E., Robinson, T., Mariosa, D., Johansson, M., . . . Yarmolinsky, J. (2023). Genetically proxied impaired GIPR signaling and risk of 6 cancers. iScience. 26(6): 106848. PMID: 37250804 https://doi.org/10.1016/j.isci.2023.106848         
  48. Sheikh, M., Brennan, P., Mariosa, D., & Robbins, H. A. (2023). Opioid medications: an emerging cancer risk factor? British Journal of Anaesthesia. 130(3): e401-e403. PMID: 36682937 https://doi.org/10.1016/j.bja.2022.12.007        
  49. Sheikh, M., Mukeriya, A., Zahed, H., Feng, X., Robbins, H. A., Shangina, O., . . . Zaridze, D. M. (2023). Smoking Cessation After Diagnosis of Kidney Cancer Is Associated With Reduced Risk of Mortality and Cancer Progression: A Prospective Cohort Study. Journal of Clinical Oncology. 41(15): 2747-2755. PMID: 36989465 https://doi.org/10.1200/JCO.22.02472  
  50. Sheikh, M., Roshandel, G., McCormack, V., & Malekzadeh, R. (2023). Current Status and Future Prospects for Esophageal Cancer. Cancers. 15(3). PMID: 36765722 https://doi.org/10.3390/cancers15030765          
  51. Sheikh, M., Virani, S., Robbins, H. A., Foretova, L., Holcatova, I., Janout, V., . . . Brennan, P. (2023). Survival and prognostic factors of early-stage non-small cell lung cancer in Central and Eastern Europe: A prospective cohort study. Cancer Med. 12(9): 10563-10574. PMID: 36952375 https://doi.org/10.1002/cam4.5791      
  52. Shi, J., Shiraishi, K., Choi, J., Matsuo, K., Chen, T. Y., Dai, J., . . . Lan, Q. (2023). Genome-wide association study of lung adenocarcinoma in East Asia and comparison with a European population. Nat Commun. 14(1): 3043. PMID: 37236969 https://doi.org/10.1038/s41467-023-38196-z     
  53. Soroush, A., Malekzadeh, R., Roshandel, G., Khoshnia, M., Poustchi, H., Kamangar, F., . . . Etemadi, A. (2023). Sex and smoking differences in the association between gastroesophageal reflux and risk of esophageal squamous cell carcinoma in a high-incidence area: Golestan Cohort Study. International Journal of Cancer. 152(6): 1137-1149. PMID: 36214797 https://doi.org/10.1002/ijc.34313
  54. Sugier, P. E., Lucotte, E. A., Domenighetti, C., Law, M. H., Iles, M. M., Brown, K., . . . Elbaz, A. (2023). Investigation of Shared Genetic Risk Factors Between Parkinson’s Disease and Cancers. Movement Disorders. 38(4): 604-615. PMID: 36788297 https://doi.org/10.1002/mds.29337       
  55. Takata, Y., Yang, J. J., Yu, D., Smith-Warner, S. A., Blot, W. J., White, E., . . . Shu, X. O. (2023). Calcium Intake and Lung Cancer Risk: A Pooled Analysis of 12 Prospective Cohort Studies. Journal of Nutrition. 153(7): 2051-2060. PMID: 36907443 https://doi.org/10.1016/j.tjnut.2023.03.011       
  56. Vasudev, N. S., Scelo, G., Glennon, K. I., Wilson, M., Letourneau, L., Eveleigh, R., . . . Banks, R. E. (2023). Application of Genomic Sequencing to Refine Patient Stratification for Adjuvant Therapy in Renal Cell Carcinoma. Clinical Cancer Research. 29(7): 1220-1231. PMID: 36815791 https://doi.org/10.1158/1078-0432.CCR-22-1936              
  57. Wu, W. Y., Haider, Z., Feng, X., Heath, A. K., Tjonneland, A., Agudo, A., . . . Johansson, M. (2023). Assessment of the EarlyCDT-Lung test as an early biomarker of lung cancer in ever-smokers: A retrospective nested case-control study in two prospective cohorts. International Journal of Cancer. 152(9): 2002-2010. PMID: 36305647 https://doi.org/10.1002/ijc.34340           
  58. Yammine, S. G., Huybrechts, I., Biessy, C., Dossus, L., Panico, S., Sanchez, M. J., . . . Chajes, V. (2023). Dietary fatty acids and endometrial cancer risk within the European Prospective Investigation into Cancer and Nutrition. BMC Cancer. 23(1): 159. PMID: 36797668 https://doi.org/10.1186/s12885-023-10611-0              
  59. Zvereva, M., Hosen, M. I., Forey, N., Sheikh, M., Kannengiesser, C., Ba, I., . . . Le Calvez-Kelm, F. (2023). Simplex Droplet Digital PCR Assays for the Detection of TERT Promoter Mutations in Urine Samples for the Non-invasive Diagnosis of Urothelial Cancer. Methods in Molecular Biology. 2684: 213-228. PMID: 37410237 https://doi.org/10.1007/978-1-0716-3291-8_13               
  60. Alcala, K., Mariosa, D., Smith-Byrne, K., Nasrollahzadeh Nesheli, D., Carreras-Torres, R., Ardanaz Aicua, E., . . . Johansson, M. (2022). The relationship between blood pressure and risk of renal cell carcinoma. International Journal of Epidemiology. 51(4): 1317-1327. PMID: 35312764 https://doi.org/10.1093/ije/dyac042              
  61. Alcala, N., & Rosenberg, N. A. (2022). Mathematical constraints on F(ST): multiallelic markers in arbitrarily many populations. Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences. 377(1852): 20200414. PMID: 35430885 https://doi.org/10.1098/rstb.2020.0414              
  62. Berndt, S. I., Vijai, J., Benavente, Y., Camp, N. J., Nieters, A., Wang, Z., . . . Rothman, N. (2022). Distinct germline genetic susceptibility profiles identified for common non-Hodgkin lymphoma subtypes. Leukemia. 36(12): 2835-2844. PMID: 36273105 https://doi.org/10.1038/s41375-022-01711-0    
  63. Bouras, E., Karhunen, V., Gill, D., Huang, J., Haycock, P. C., Gunter, M. J., . . . Tsilidis, K. K. (2022). Circulating inflammatory cytokines and risk of five cancers: a Mendelian randomization analysis. BMC Medicine. 20(1): 3. PMID: 35012533 https://doi.org/10.1186/s12916-021-02193-0    
  64. Bouvard, V., Nethan, S. T., Singh, D., Warnakulasuriya, S., Mehrotra, R., Chaturvedi, A. K., . . . Lauby-Secretan, B. (2022). IARC Perspective on Oral Cancer Prevention. New England Journal of Medicine. 387(21): 1999-2005. PMID: 36378601 https://doi.org/10.1056/NEJMsr2210097             
  65. Breeur, M., Ferrari, P., Dossus, L., Jenab, M., Johansson, M., Rinaldi, S., . . . Viallon, V. (2022). Pan-cancer analysis of pre-diagnostic blood metabolite concentrations in the European Prospective Investigation into Cancer and Nutrition. BMC Medicine. 20(1): 351. PMID: 36258205 https://doi.org/10.1186/s12916-022-02553-4        
  66. Brennan, P., & Davey-Smith, G. (2022). Identifying Novel Causes of Cancers to Enhance Cancer Prevention: New Strategies Are Needed. Journal of the National Cancer Institute. 114(3): 353-360. PMID: 34743211 https://doi.org/10.1093/jnci/djab204               
  67. Bukavina, L., Bensalah, K., Bray, F., Carlo, M., Challacombe, B., Karam, J. A., . . . Psutka, S. P. (2022). Epidemiology of Renal Cell Carcinoma: 2022 Update. European Urology. 82(5): 529-542. PMID: 36100483 https://doi.org/10.1016/j.eururo.2022.08.019
  68. Byun, J., Han, Y., Li, Y., Xia, J., Long, E., Choi, J., . . . Amos, C. I. (2022). Cross-ancestry genome-wide meta-analysis of 61,047 cases and 947,237 controls identifies new susceptibility loci contributing to lung cancer. Nature Genetics. 54(8): 1167-1177. PMID: 35915169 https://doi.org/10.1038/s41588-022-01115-x  
  69. Cai, J., Chen, H., Lu, M., Zhang, Y., Lu, B., Luo, C., . . . Zhao, Y. (2022). Association between Temporal Glycemic Change and Risk of Pancreatic Cancer in Men: A Prospective Cohort Study. Cancers. 14(14): 12. PMID: 35884465 https://doi.org/10.3390/cancers14143403          
  70. Claeys, L., De Saeger, S., Scelo, G., Biessy, C., Casagrande, C., Nicolas, G., . . . Huybrechts, I. (2022). Mycotoxin Exposure and Renal Cell Carcinoma Risk: An Association Study in the EPIC European Cohort. Nutrients. 14(17): 3581. PMID: 36079840 https://doi.org/10.3390/nu14173581    
  71. Clasen, J. L., Heath, A. K., Van Puyvelde, H., Huybrechts, I., Park, J. Y., Ferrari, P., . . . Muller, D. C. (2022). Biomarkers of the transsulfuration pathway and risk of renal cell carcinoma in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. International Journal of Cancer. 151(5): 708-716. PMID: 35366005 https://doi.org/10.1002/ijc.34009           
  72. Collatuzzo, G., Etemadi, A., Sotoudeh, M., Nikmanesh, A., Poustchi, H., Khoshnia, M., . . . Malekzadeh, R. (2022). Meat consumption and risk of esophageal and gastric cancer in the Golestan Cohort Study, Iran. International Journal of Cancer. 151(7): 1005-1012. PMID: 35489023 https://doi.org/10.1002/ijc.34056            
  73. Di Genova, A., Mangiante, L., Sexton-Oates, A., Voegele, C., Fernandez-Cuesta, L., Alcala, N., & Foll, M. (2022). A molecular phenotypic map of malignant pleural mesothelioma. Gigascience. 12. PMID: 36705549 https://doi.org/10.1093/gigascience/giac128  
  74. Di Genova, A., Mangiante, L., Sexton-Oates, A., Voegele, C., Fernandez-Cuesta, L., Alcala, N., & Foll, M. (2022). A molecular phenotypic map of malignant pleural mesothelioma. Gigascience. 12: 13. PMID: 36705549 https://doi.org/10.1093/gigascience/giac128               
  75. Dianatinasab, M., Wesselius, A., Salehi-Abargouei, A., Yu, E. Y. W., Fararouei, M., Brinkman, M., . . . Zeegers, M. P. (2022). Dietary fats and their sources in association with the risk of bladder cancer: A pooled analysis of 11 prospective cohort studies. International Journal of Cancer. 151(1): 44-55. PMID: 35182086 https://doi.org/10.1002/ijc.33970           
  76. Ecke, T. H., Le Calvez-Kelm, F., & Otto, T. (2022). Molecular Diagnostic and Prognostication Assays for the Subtyping of Urinary Bladder Cancer Are on the Way to Illuminating Our Vision. International Journal of Molecular Sciences. 23(10): 5620. PMID: 35628431 https://doi.org/10.3390/ijms23105620            
  77. Emerson, M. A., Farquhar, D. R., Lenze, N. R., Sheth, S., Mazul, A. L., Zanation, A. M., . . . Olshan, A. F. (2022). Socioeconomic status, access to care, risk factor patterns, and stage at diagnosis for head and neck cancer among black and white patients. Head and Neck. 44(4): 823-834. PMID: 35044015 https://doi.org/10.1002/hed.26977
  78. Etemadi, A., Hariri, S., Hassanian-Moghaddam, H., Poustchi, H., Roshandel, G., Shayanrad, A., . . . Abnet, C. C. (2022). Lead poisoning among asymptomatic individuals with a long-term history of opiate use in Golestan Cohort Study. International Journal on Drug Policy. 104: 103695. PMID: 35472727 https://doi.org/10.1016/j.drugpo.2022.103695
  79. Feng, X. S., Zahed, H., & Robbins, H. A. (2022). Editorial Comment. Journal of Urology. 207(2): 332. PMID: 34781695 https://doi.org/10.1097/JU.0000000000002249.01             
  80. Gabriel, A. A. G., Atkins, J. R., Penha, R. C. C., Smith-Byrne, K., Gaborieau, V., Voegele, C., . . . McKay, J. D. (2022). Genetic Analysis of Lung Cancer and the Germline Impact on Somatic Mutation Burden. Journal of the National Cancer Institute. 114(8): 1159-1166. PMID: 35511172 https://doi.org/10.1093/jnci/djac087      
  81. Galati, L., Combes, J. D., Le Calvez-Kelm, F., McKay-Chopin, S., Forey, N., Ratel, M., . . . Gheit, T. (2022). Detection of Circulating HPV16 DNA as a Biomarker for Cervical Cancer by a Bead-Based HPV Genotyping Assay. Microbiol Spectr. 10(2): e0148021. PMID: 35225653 https://doi.org/10.1128/spectrum.01480-21  
  82. Gislon, L. C., Curado, M. P., Lopez, R. V. M., de Oliveira, J. C., Vasconcelos de Podesta, J. R., Ventorin von Zeidler, S., . . . Kowalski, L. P. (2022). Risk factors associated with head and neck cancer in former smokers: A Brazilian multicentric study. Cancer Epidemiology. 78: 102143. PMID: 35378425 https://doi.org/10.1016/j.canep.2022.102143    
  83. Gormley, M., Dudding, T., Kachuri, L., Burrows, K., Chong, A. H. W., Martin, R. M., . . . Richmond, R. C. (2022). Investigating the effect of sexual behaviour on oropharyngeal cancer risk: a methodological assessment of Mendelian randomization. BMC Medicine. 20(1): 40. PMID: 35094705 https://doi.org/10.1186/s12916-022-02233-3    
  84. Guida, F., Kidman, R., Ferlay, J., Schuz, J., Soerjomataram, I., Kithaka, B., . . . McCormack, V. (2022). Global and regional estimates of orphans attributed to maternal cancer mortality in 2020. Nature Medicine. 28(12): 2563-2572. PMID: 36404355 https://doi.org/10.1038/s41591-022-02109-2    
  85. Hadji, M., Rashidian, H., Marzban, M., Naghibzadeh-Tahami, A., Gholipour, M., Mohebbi, E., . . . Pukkala, E. (2022). Opium use and risk of bladder cancer: a multi-centre case-referent study in Iran. International Journal of Epidemiology. 51(3): 830-838. PMID: 35244716 https://doi.org/10.1093/ije/dyac031
  86. Hasanau, T., Pisarev, E., Kisil, O., Nonoguchi, N., Le Calvez-Kelm, F., & Zvereva, M. (2022). Detection of TERT Promoter Mutations as a Prognostic Biomarker in Gliomas: Methodology, Prospects, and Advances. Biomedicines. 10(3). PMID: 35327529 https://doi.org/10.3390/biomedicines10030728              
  87. Hejazi, E., Emamat, H., Sharafkhah, M., Saidpour, A., Poustchi, H., Sepanlou, S., . . . Hekmatdoost, A. (2022). Dietary acid load and mortality from all causes, CVD and cancer: results from the Golestan Cohort Study. British Journal of Nutrition. 128(2): 237-243. PMID: 34392847 https://doi.org/10.1017/S0007114521003135              
  88. Hemissi, I., Boussetta, S., Dallali, H., Hellal, F., Durand, G., Voegele, C., . . . Ouerhani, S. (2022). Development of a custom next-generation sequencing panel for the determination of bladder cancer risk in a Tunisian cohort. Molecular Biology Reports. 49(2): 1233-1258. PMID: 34854013 https://doi.org/10.1007/s11033-021-06951-4               
  89. Hemissi, I., Boussetta, S., Dallali, H., Hellal, F., Durand, G., Voegele, C., . . . Ouerhani, S. (2022). Correction to: Development of a custom next-generation sequencing panel for the determination of bladder cancer risk in a Tunisian cohort. Molecular Biology Reports. 49(2): 1259. PMID: 34977990 https://doi.org/10.1007/s11033-021-07052-y               
  90. Hong, W., Li, A., Liu, Y., Xiao, X., Christiani, D. C., Hung, R. J., . . . Cheng, C. (2022). Clonal Hematopoiesis Mutations in Patients with Lung Cancer Are Associated with Lung Cancer Risk Factors. Cancer Research. 82(2): 199-209. PMID: 34815255 https://doi.org/10.1158/0008-5472.CAN-21-1903            
  91. Islam, S. M. A., Diaz-Gay, M., Wu, Y., Barnes, M., Vangara, R., Bergstrom, E. N., . . . Alexandrov, L. B. (2022). Uncovering novel mutational signatures by de novo extraction with SigProfilerExtractor. Cell Genom. 2(11): None. PMID: 36388765 https://doi.org/10.1016/j.xgen.2022.100179      
  92. Kolijn, P. M., Hosnijeh, F. S., Spath, F., Hengeveld, P. J., Agathangelidis, A., Saleh, M., . . . Langerak, A. W. (2022). High-risk subtypes of chronic lymphocytic leukemia are detectable as early as 16 years prior to diagnosis. Blood. 139(10): 1557-1563. PMID: 34662377 https://doi.org/10.1182/blood.2021012890   
  93. Li, M., Zhang, L., Charvat, H., Callister, M. E., Sasieni, P., Christodoulou, E., . . . Robbins, H. A. (2022). The influence of postscreening follow-up time and participant characteristics on estimates of overdiagnosis from lung cancer screening trials. International Journal of Cancer. 151(9): 1491-1501. PMID: 35809038 https://doi.org/10.1002/ijc.34167           
  94. Li, Y., Xiao, X., Li, J., Byun, J., Cheng, C., Bosse, Y., . . . consortium, I.-I. l. c. (2022). Genome-wide interaction analysis identified low-frequency variants with sex disparity in lung cancer risk. Human Molecular Genetics. 31(16): 2831-2843. PMID: 35138370 https://doi.org/10.1093/hmg/ddac030  
  95. Mariosa, D., Smith-Byrne, K., Richardson, T. G., Ferrari, P., Gunter, M. J., Papadimitriou, N., . . . Johansson, M. (2022). Body Size at Different Ages and Risk of 6 Cancers: A Mendelian Randomization and Prospective Cohort Study. Journal of the National Cancer Institute. 114(9): 1296-1300. PMID: 35438160 https://doi.org/10.1093/jnci/djac061     
  96. Masukume, G., Mmbaga, B. T., Dzamalala, C. P., Mlombe, Y. B., Finch, P., Nyakunga-Maro, G., . . . McCormack, V. (2022). A very-hot food and beverage thermal exposure index and esophageal cancer risk in Malawi and Tanzania: findings from the ESCCAPE case-control studies. British Journal of Cancer. 127(6): 1106-1115. PMID: 35768549 https://doi.org/10.1038/s41416-022-01890-8    
  97. Mc Leer, A., Foll, M., Brevet, M., Antoine, M., Novello, S., Mondet, J., . . . Moro-Sibilot, D. (2022). Detection of acquired TERT amplification in addition to predisposing p53 and Rb pathways alterations in EGFR-mutant lung adenocarcinomas transformed into small-cell lung cancers. Lung Cancer. 167: 98-106. PMID: 35183375 https://doi.org/10.1016/j.lungcan.2022.01.008
  98. Middleton, D. R. S., Mmbaga, B. T., Menya, D., Dzamalala, C., Nyakunga-Maro, G., Finch, P., . . . Esccape (2022). Alcohol consumption and oesophageal squamous cell cancer risk in east Africa: findings from the large multicentre ESCCAPE case-control study in Kenya, Tanzania, and Malawi. Lancet Glob Health. 10(2): e236-e245. PMID: 34921758 https://doi.org/10.1016/S2214-109X(21)00506-4        
  99. Moonen, L., Mangiante, L., Leunissen, D. J. G., Lap, L. M. V., Gabriel, A., Hillen, L. M., . . . Speel, E. M. (2022). Differential Orthopedia Homeobox expression in pulmonary carcinoids is associated with changes in DNA methylation. International Journal of Cancer. 150(12): 1987-1997. PMID: 35076935 https://doi.org/10.1002/ijc.33939               
  100. Morrison, M. L., Alcala, N., & Rosenberg, N. A. (2022). FSTruct: An F(ST) -based tool for measuring ancestry variation in inference of population structure. Molecular Ecology Resources. 22(7): 2614-2626. PMID: 35596736 https://doi.org/10.1111/1755-0998.13647       
  101. Mountzias, A., Hultdin, J., Hlodan, J., Kroger Dahlin, B. I., Johansson, M., & Ljungberg, B. (2022). Inflammatory response markers and survival prediction in patients with renal cell carcinoma. Scand J Urol. 56(1): 47-52. PMID: 34586034 https://doi.org/10.1080/21681805.2021.1983016           
  102. Nomburg, J., Bullman, S., Nasrollahzadeh, D., Collisson, E. A., Abedi-Ardekani, B., Akoko, L. O., . . . Van Loon, K. (2022). An international report on bacterial communities in esophageal squamous cell carcinoma. International Journal of Cancer. 151(11): 1947-1959. PMID: 35837755 https://doi.org/10.1002/ijc.34212
  103. Pakmanesh, H., Anvari, O., Forey, N., Weiderpass, E., Malekpourafshar, R., Iranpour, M., . . . Calvez-Kelm, F. L. (2022). TERT Promoter Mutations as Simple and Non-Invasive Urinary Biomarkers for the Detection of Urothelial Bladder Cancer in a High-Risk Region. International Journal of Molecular Sciences. 23(22): 14319. PMID: 36430798 https://doi.org/10.3390/ijms232214319              
  104. Pastorino, R., Sassano, M., Danilo Tiziano, F., Giraldi, L., Amore, R., Arzani, D., . . . Boccia, S. (2022). Plasma miR-151-3p as a Candidate Diagnostic Biomarker for Head and Neck Cancer: A Cross-sectional Study within the INHANCE Consortium. Cancer Epidemiology, Biomarkers and Prevention. 31(12): 2237-2243. PMID: 36126276 https://doi.org/10.1158/1055-9965.EPI-22-0376              
  105. Perdomo, S., Lopez, J., Torres-Ibarguen, M. Z., Puerto-Jimenez, D. N., & de Vries, E. (2022). Modelling the Reduction in Cancer Incidence After Variations in the Prevalence of Tobacco Consumption in Colombia in the Period 2016-2050. Cancer Control. 29: 10732748221121390. PMID: 36415920 https://doi.org/10.1177/10732748221121390   
  106. Petrovic, D., Bodinier, B., Dagnino, S., Whitaker, M., Karimi, M., Campanella, G., . . . Chadeau-Hyam, M. (2022). Epigenetic mechanisms of lung carcinogenesis involve differentially methylated CpG sites beyond those associated with smoking. European Journal of Epidemiology. 37(6): 629-640. PMID: 35595947 https://doi.org/10.1007/s10654-022-00877-2     
  107. Popovic, M., Fiano, V., Moirano, G., Chiusa, L., Conway, D. I., Garzino Demo, P., . . . Richiardi, L. (2022). The Impact of the COVID-19 Pandemic on Head and Neck Cancer Diagnosis in the Piedmont Region, Italy: Interrupted Time-Series Analysis. Front Public Health. 10: 809283. PMID: 35265573 https://doi.org/10.3389/fpubh.2022.809283           
  108. Porta, M., Gasull, M., Pumarega, J., Kiviranta, H., Rantakokko, P., Raaschou-Nielsen, O., . . . Vineis, P. (2022). Plasma concentrations of persistent organic pollutants and pancreatic cancer risk. International Journal of Epidemiology. 51(2): 479-490. PMID: 34259837 https://doi.org/10.1093/ije/dyab115
  109. Robbins, H. A., Cheung, L. C., Chaturvedi, A. K., Baldwin, D. R., Berg, C. D., & Katki, H. A. (2022). Management of Lung Cancer Screening Results Based on Individual Prediction of Current and Future Lung Cancer Risks. Journal of Thoracic Oncology. 17(2): 252-263. PMID: 34648946 https://doi.org/10.1016/j.jtho.2021.10.001       
  110. Robbins, H. A., Ferreiro-Iglesias, A., Waterboer, T., Brenner, N., Nygard, M., Bender, N., . . . Brennan, P. (2022). Absolute Risk of Oropharyngeal Cancer After an HPV16-E6 Serology Test and Potential Implications for Screening: Results From the Human Papillomavirus Cancer Cohort Consortium. Journal of Clinical Oncology. 40(31): 3613-3622. PMID: 35700419 https://doi.org/10.1200/JCO.21.01785        
  111. Robbins, H. A., Landy, R., & Ahluwalia, J. S. (2022). Achieving Equity in Lung Cancer Screening for Black Individuals Requires Innovation to Move Beyond “Equal” Guidelines. JAMA Oncol. 8(4): 1-2. PMID: 35201279 https://doi.org/10.1001/jamaoncol.2021.7252               
  112. Robbins, H. A., Zahed, H., Lebrett, M. B., Balata, H., Johansson, M., Sharman, A., . . . Crosbie, P. A. J. (2022). Explaining differences in the frequency of lung cancer detection between the National Lung Screening Trial and community-based screening in Manchester, UK. Lung Cancer. 171: 61-64. PMID: 35917648 https://doi.org/10.1016/j.lungcan.2022.07.017
  113. Rosenberger, A., Muttray, N., Hung, R. J., Christiani, D. C., Caporaso, N. E., Liu, G., . . . Consortium, I.-I. (2022). Gene-gene interaction of AhRwith and within the Wntcascade affects susceptibility to lung cancer. European Journal of Medical Research. 27(1): 14. PMID: 35101137 https://doi.org/10.1186/s40001-022-00638-7               
  114. Schmid, S., Jiang, M., Brown, M. C., Fares, A., Garcia, M., Soriano, J., . . . Liu, G. (2022). Accounting for EGFR Mutations in Epidemiologic Analyses of Non-Small Cell Lung Cancers: Examples Based on the International Lung Cancer Consortium Data. Cancer Epidemiology, Biomarkers and Prevention. 31(3): 679-687. PMID: 35027437 https://doi.org/10.1158/1055-9965.EPI-21-0747              
  115. Sichero, L., Tagliabue, M., Mota, G., Ferreira, S., Nunes, R. A. L., Castaneda, C. A., . . . Group, H. E. S. (2022). Biomarkers of human papillomavirus (HPV)-driven head and neck cancer in Latin America and Europe study: Study design and HPV DNA/p16(INK4a) status. Head and Neck. 44(1): 122-133. PMID: 34726297 https://doi.org/10.1002/hed.26912    
  116. Simoens, C., Gheit, T., Ridder, R., Gorbaslieva, I., Holzinger, D., Lucas, E., . . . group, H.-A. s. (2022). Accuracy of high-risk HPV DNA PCR, p16((INK4a)) immunohistochemistry or the combination of both to diagnose HPV-driven oropharyngeal cancer. BMC Infectious Diseases. 22(1): 676. PMID: 35933382 https://doi.org/10.1186/s12879-022-07654-2     
  117. Simon, J., Brenner, N., Reich, S., Langseth, H., Hansen, B. T., Ursin, G., . . . Waterboer, T. (2022). Nasopharyngeal carcinoma patients from Norway show elevated Epstein-Barr virus IgA and IgG antibodies prior to diagnosis. Cancer Epidemiology. 77: 102117. PMID: 35121404 https://doi.org/10.1016/j.canep.2022.102117
  118. Smith-Byrne, K., Cerani, A., Guida, F., Zhou, S., Agudo, A., Aleksandrova, K., . . . Richards, J. B. (2022). Circulating Isovalerylcarnitine and Lung Cancer Risk: Evidence from Mendelian Randomization and Prediagnostic Blood Measurements. Cancer Epidemiology, Biomarkers and Prevention. 31(10): 1966-1974. PMID: 35839461 https://doi.org/10.1158/1055-9965.EPI-21-1033              
  119. Tran, K. B., Lang, J. J., Compton, K., Xu, R. X., Acheson, A. R., Henrikson, H. J., . . . Murray, C. J. L. (2022). The global burden of cancer attributable to risk factors, 2010-19: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 400(10352): 563-591. PMID: 35988567 https://doi.org/10.1016/S0140-6736(22)01438-6            
  120. Wade, K. H., Yarmolinsky, J., Giovannucci, E., Lewis, S. J., Millwood, I. Y., Munafo, M. R., . . . with the M. R. in Nutrition, C. w. g. (2022). Applying Mendelian randomization to appraise causality in relationships between nutrition and cancer. Cancer Causes and Control. 33(5): 631-652. PMID: 35274198 https://doi.org/10.1007/s10552-022-01562-1             
  121. Watts, E. L., Perez-Cornago, A., Fensom, G. K., Smith-Byrne, K., Noor, U., Andrews, C. D., . . . Travis, R. C. (2022). Circulating free testosterone and risk of aggressive prostate cancer: Prospective and Mendelian randomisation analyses in international consortia. International Journal of Cancer. 151(7): 1033-1046. PMID: 35579976 https://doi.org/10.1002/ijc.34116           
  122. Yang, J. J., Yu, D., White, E., Lee, D. H., Blot, W., Robien, K., . . . Shu, X. O. (2022). Prediagnosis Leisure-Time Physical Activity and Lung Cancer Survival: A Pooled Analysis of 11 Cohorts. JNCI Cancer Spectr. 6(2): 11. PMID: 35603841 https://doi.org/10.1093/jncics/pkac009
  123. Yang, W., Liu, H., Zhang, R., Freedman, J. A., Han, Y., Hung, R. J., . . . Wei, Q. (2022). Deciphering associations between three RNA splicing-related genetic variants and lung cancer risk. NPJ Precis Oncol. 6(1): 48. PMID: 35773316 https://doi.org/10.1038/s41698-022-00281-9    
  124. Yao, S., Campbell, P. T., Ugai, T., Gierach, G., Abubakar, M., Adalsteinsson, V., . . . Ogino, S. (2022). Proceedings of the fifth international Molecular Pathological Epidemiology (MPE) meeting. Cancer Causes and Control. 33(8): 1107-1120. PMID: 35759080 https://doi.org/10.1007/s10552-022-01594-7    
  125. Yarmolinsky, J., Amos, C. I., Hung, R. J., Moreno, V., Burrows, K., Smith-Byrne, K., . . . Davey Smith, G. (2022). Association of germline TYK2 variation with lung cancer and non-Hodgkin lymphoma risk. International Journal of Cancer. 151(12): 2155-2160. PMID: 35747941 https://doi.org/10.1002/ijc.34180      
  126. Zhang, R., Shen, S., Wei, Y., Zhu, Y., Li, Y., Chen, J., . . . Christiani, D. C. (2022). A Large-Scale Genome-Wide Gene-Gene Interaction Study of Lung Cancer Susceptibility in Europeans With a Trans-Ethnic Validation in Asians. Journal of Thoracic Oncology. 17(8): 974-990. PMID: 35500836 https://doi.org/10.1016/j.jtho.2022.04.011       
  127. Abedi-Ardekani, B., Nasrollahzadeh, D., Egevad, L., Banks, R. E., Vasudev, N., Holcatova, I., . . . Scelo, G. (2021). Morphological findings in frozen non-neoplastic kidney tissues of patients with kidney cancer from large-scale multicentric studies on renal cancer. Virchows Arch. 478(6): 1099-1107. PMID: 33403511  doi: 10.1007/s00428-020-02986-3
  128. Aredo, J. V., Luo, S. J., Gardner, R. M., Sanyal, N., Choi, E., Hickey, T. P., . . . Han, S. S. (2021). Tobacco Smoking and Risk of Second Primary Lung Cancer. J Thorac Oncol. 16(6): 968-979. PMID: 33722709  doi: 10.1016/j.jtho.2021.02.024
  129. Baldwin, D. R., Callister, M. E., Crosbie, P. A., O’Dowd, E. L., Rintoul, R. C., Robbins, H. A., & Steele, R. J. C. (2021). Biomarkers in lung cancer screening: the importance of study design. Eur Respir J. 57(1). PMID: 33446580  doi: 10.1183/13993003.04367-2020
  130. Barker, J., Smith-Byrne, K., Sayers, O., Joseph, K., Sleeman, M., Lasserson, D., & Vaux, E. (2021). Electronic alerts for acute kidney injury across primary and secondary care. BMJ Open Qual. 10(2): 7. PMID: 33972363  doi: 10.1136/bmjoq-2020-000956
  131. Baumeister, S. E., Baurecht, H., Nolde, M., Alayash, Z., Glaser, S., Johansson, M., . . . Hung, R. J. (2021). Cannabis Use, Pulmonary Function, and Lung Cancer Susceptibility: A Mendelian Randomization Study. J Thorac Oncol. 16(7): 1127-1135. PMID: 33852959  doi: 10.1016/j.jtho.2021.03.025
  132. Bray, M. J., Chen, L. S., Fox, L., Ma, Y., Grucza, R. A., Hartz, S. M., . . . Bierut, L. J. (2021). Studying the Utility of Using Genetics to Predict Smoking-Related Outcomes in a Population-Based Study and a Selected Cohort. Nicotine Tob Res. 23(12): 2110-2116. PMID: 33991188  doi: 10.1093/ntr/ntab100
  133. Byun, J., Han, Y., Ostrom, Q. T., Edelson, J., Walsh, K. M., Pettit, R. W., . . . for, I.-I. (2021). The Shared Genetic Architectures Between Lung Cancer and Multiple Polygenic Phenotypes in Genome-Wide Association Studies. Cancer Epidemiol Biomarkers Prev. 30(6): 1156-1164. PMID: 33771847  doi: 10.1158/1055-9965.EPI-20-1635
  134. Callister, M. E. J., Sasieni, P., & Robbins, H. A. (2021). Overdiagnosis in lung cancer screening. Lancet Respir Med. 9(1): 7-9. PMID: 33412118  doi: 10.1016/S2213-2600(20)30553-1
  135. Chen, H., Majumdar, A., Wang, L., Kar, S., Brown, K. M., Feng, H., . . . Lindstrom, S. (2021). Large-scale cross-cancer fine-mapping of the 5p15.33 region reveals multiple independent signals. HGG Adv. 2(3): 100041. PMID: 34355204  doi: 10.1016/j.xhgg.2021.100041
  136. Christakoudi, S., Pagoni, P., Ferrari, P., Cross, A. J., Tzoulaki, I., Muller, D. C., . . . Tsilidis, K. K. (2021). Weight change in middle adulthood and risk of cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. Int J Cancer. 148(7): 1637-1651. PMID: 33038275  doi: 10.1002/ijc.33339
  137. Clasen, J. L., Heath, A. K., Van Puyvelde, H., Huybrechts, I., Park, J. Y., Ferrari, P., . . . Muller, D. C. (2021). A comparison of complementary measures of vitamin B6 status, function, and metabolism in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Am J Clin Nutr. 114(1): 338-347. PMID: 33829249  doi: 10.1093/ajcn/nqab045
  138. Collaboration, N. C. D. R. F. (2021). Heterogeneous contributions of change in population distribution of body mass index to change in obesity and underweight. Elife. 10. PMID: 33685583  doi: 10.7554/eLife.60060
  139. Collaboration, N. C. D. R. F. (2021). Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet. 398(10304): 957-980. PMID: 34450083  doi: 10.1016/S0140-6736(21)01330-1
  140. Conway, D. I., Hovanec, J., Ahrens, W., Ross, A., Holcatova, I., Lagiou, P., . . . McMahon, A. D. (2021). Occupational socioeconomic risk associations for head and neck cancer in Europe and South America: individual participant data analysis of pooled case-control studies within the INHANCE Consortium. J Epidemiol Community Health. 75(8): 779-787. PMID: 33622804  doi: 10.1136/jech-2020-214913
  141. Cree, I. A., Indave Ruiz, B. I., Zavadil, J., McKay, J., Olivier, M., Kozlakidis, Z., . . . participants, I. R. (2021). The International Collaboration for Cancer Classification and Research. Int J Cancer. 148(3): 560-571. PMID: 32818326  doi: 10.1002/ijc.33260
  142. Dagnino, S., Bodinier, B., Guida, F., Smith-Byrne, K., Petrovic, D., Whitaker, M. D., . . . Chadeau-Hyam, M. (2021). Prospective Identification of Elevated Circulating CDCP1 in Patients Years before Onset of Lung Cancer. Cancer Res. 81(13): 3738-3748. PMID: 33574093  doi: 10.1158/0008-5472.CAN-20-3454
  143. Dianatinasab, M., Wesselius, A., de Loeij, T., Salehi-Abargouei, A., Yu, E. Y. W., Fararouei, M., . . . Zeegers, M. P. (2021). The association between meat and fish consumption and bladder cancer risk: a pooled analysis of 11 cohort studies. Eur J Epidemiol. 36(8): 781-792. PMID: 34036467  doi: 10.1007/s10654-021-00762-4
  144. Dimou, N., Mori, N., Harlid, S., Harbs, J., Martin, R. M., Smith-Byrne, K., . . . Murphy, N. (2021). Circulating Levels of Testosterone, Sex Hormone Binding Globulin and Colorectal Cancer Risk: Observational and Mendelian Randomization Analyses. Cancer Epidemiol Biomarkers Prev. 30(7): 1336-1348. PMID: 33879453  doi: 10.1158/1055-9965.EPI-20-1690
  145. Dimou, N. L., Papadimitriou, N., Mariosa, D., Johansson, M., Brennan, P., Peters, U., . . . Murphy, N. (2021). Circulating adipokine concentrations and risk of five obesity-related cancers: A Mendelian randomization study. Int J Cancer. 148(7): 1625-1636. PMID: 33038280  doi: 10.1002/ijc.33338
  146. Fernandez-Cuesta, L., Mangiante, L., Alcala, N., & Foll, M. (2021). Challenges in lung and thoracic pathology: molecular advances in the classification of pleural mesotheliomas. Virchows Arch. 478(1): 73-80. PMID: 33411030  doi: 10.1007/s00428-020-02980-9
  147. Ferreiro-Iglesias, A., McKay, J. D., Brenner, N., Virani, S., Lesseur, C., Gaborieau, V., . . . Brennan, P. (2021). Germline determinants of humoral immune response to HPV-16 protect against oropharyngeal cancer. Nat Commun. 12(1): 5945. PMID: 34642315  doi: 10.1038/s41467-021-26151-9
  148. Ghasemi-Kebria, F., Jafari-Delouie, N., Amiriani, T., Norouzi, A., Abedi-Ardekani, B., Nasrollahzadeh, D., . . . Roshandel, G. (2021). Building a Cancer Biobank in a Low-Resource Setting in Northern Iran: the Golestan Cancer Biobank. Arch Iran Med. 24(7): 526-533. PMID: 34488317  doi: 10.34172/aim.2021.75
  149. Ginsburg, O., Ashton-Prolla, P., Cantor, A., Mariosa, D., & Brennan, P. (2021). The role of genomics in global cancer prevention. Nat Rev Clin Oncol. 18(2): 116-128. PMID: 32973296  doi: 10.1038/s41571-020-0428-5
  150. Gonzalez Maldonado, S., Hynes, L. C., Motsch, E., Heussel, C. P., Kauczor, H. U., Robbins, H. A., . . . Kaaks, R. (2021). Validation of multivariable lung cancer risk prediction models for the personalized assignment of optimal screening frequency: a retrospective analysis of data from the German Lung Cancer Screening Intervention Trial (LUSI). Transl Lung Cancer Res. 10(3): 1305-1317. PMID: 33889511  doi: 10.21037/tlcr-20-1173
  151. Gormley, M., Yarmolinsky, J., Dudding, T., Burrows, K., Martin, R. M., Thomas, S., . . . Richmond, R. C. (2021). Using genetic variants to evaluate the causal effect of cholesterol lowering on head and neck cancer risk: A Mendelian randomization study. PLoS Genet. 17(4): e1009525. PMID: 33886544  doi: 10.1371/journal.pgen.1009525
  152. Guida, F., Tan, V. Y., Corbin, L. J., Smith-Byrne, K., Alcala, K., Langenberg, C., . . . Johansson, M. (2021). The blood metabolome of incident kidney cancer: A case-control study nested within the MetKid consortium. PLoS Med. 18(9): e1003786. PMID: 34543281  doi: 10.1371/journal.pmed.1003786
  153. Hadji, M., Rashidian, H., Marzban, M., Gholipour, M., Naghibzadeh-Tahami, A., Mohebbi, E., . . . Zendehdel, K. (2021). The Iranian Study of Opium and Cancer (IROPICAN): Rationale, Design, and Initial Findings. Arch Iran Med. 24(3): 167-176. PMID: 33878874  doi: 10.34172/aim.2021.27
  154. Hashemian, M., Merat, S., Poustchi, H., Jafari, E., Radmard, A. R., Kamangar, F., . . . Etemadi, A. (2021). Red Meat Consumption and Risk of Nonalcoholic Fatty Liver Disease in a Population With Low Meat Consumption: The Golestan Cohort Study. Am J Gastroenterol. 116(8): 1667-1675. PMID: 33767101  doi: 10.14309/ajg.0000000000001229
  155. Hubert, J. N., Suybeng, V., Vallee, M., Delhomme, T. M., Maubec, E., Boland, A., . . . Chanudet, E. (2021). The PI3K/mTOR Pathway Is Targeted by Rare Germline Variants in Patients with Both Melanoma and Renal Cell Carcinoma. Cancers (Basel). 13(9). PMID: 34067022  doi: 10.3390/cancers13092243
  156. Hung, R. J., Warkentin, M. T., Brhane, Y., Chatterjee, N., Christiani, D. C., Landi, M. T., . . . Amos, C. I. (2021). Assessing Lung Cancer Absolute Risk Trajectory Based on a Polygenic Risk Model. Cancer Res. 81(6): 1607-1615. PMID: 33472890  doi: 10.1158/0008-5472.CAN-20-1237
  157. Julian-Serrano, S., Yuan, F., Wheeler, W., Benyamin, B., Machiela, M. J., Arslan, A. A., . . . Stolzenberg-Solomon, R. Z. (2021). Hepcidin-regulating iron metabolism genes and pancreatic ductal adenocarcinoma: a pathway analysis of genome-wide association studies. Am J Clin Nutr. 114(4): 1408-1417. PMID: 34258619  doi: 10.1093/ajcn/nqab217
  158. Kliemann, N., Viallon, V., Murphy, N., Beeken, R. J., Rothwell, J. A., Rinaldi, S., . . . Gunter, M. J. (2021). Metabolic signatures of greater body size and their associations with risk of colorectal and endometrial cancers in the European Prospective Investigation into Cancer and Nutrition. BMC Med. 19(1): 101. PMID: 33926456  doi: 10.1186/s12916-021-01970-1
  159. Landy, R., Young, C. D., Skarzynski, M., Cheung, L. C., Berg, C. D., Rivera, M. P., . . . Katki, H. A. (2021). Using Prediction Models to Reduce Persistent Racial and Ethnic Disparities in the Draft 2020 USPSTF Lung Cancer Screening Guidelines. J Natl Cancer Inst. 113(11): 1590-1594. PMID: 33399825  doi: 10.1093/jnci/djaa211
  160. Laskar, R., Ferreiro-Iglesias, A., Bishop, D. T., Iles, M. M., Kanetsky, P. A., Armstrong, B. K., . . . Cust, A. E. (2021). Risk factors for melanoma by anatomical site: an evaluation of aetiological heterogeneity. Br J Dermatol. 184(6): 1085-1093. PMID: 33270213  doi: 10.1111/bjd.19705
  161. Laskar, R. S., Li, P., Ecsedi, S., Abedi-Ardekani, B., Durand, G., Robinot, N., . . . Chanudet, E. (2021). Sexual dimorphism in cancer: insights from transcriptional signatures in kidney tissue and renal cell carcinoma. Hum Mol Genet. 30(5): 343-355. PMID: 33527138  doi: 10.1093/hmg/ddab031
  162. Lesseur, C., Ferreiro-Iglesias, A., McKay, J. D., Bosse, Y., Johansson, M., Gaborieau, V., . . . Brennan, P. (2021). Genome-wide association meta-analysis identifies pleiotropic risk loci for aerodigestive squamous cell cancers. PLoS Genet. 17(3): e1009254. PMID: 33667223  doi: 10.1371/journal.pgen.1009254
  163. Liu, Y., Xia, J., McKay, J., Tsavachidis, S., Xiao, X., Spitz, M. R., . . . Amos, C. I. (2021). Rare deleterious germline variants and risk of lung cancer. NPJ Precis Oncol. 5(1): 12. PMID: 33594163  doi: 10.1038/s41698-021-00146-7
  164. Liu, Z., Derkach, A., Yu, K. J., Yeager, M., Chang, Y. S., Chen, C. J., . . . Pfeiffer, R. M. (2021). Patterns of Human Leukocyte Antigen Class I and Class II Associations and Cancer. Cancer Res. 81(4): 1148-1152. PMID: 33272927  doi: 10.1158/0008-5472.CAN-20-2292
  165. Loftfield, E., Stepien, M., Viallon, V., Trijsburg, L., Rothwell, J. A., Robinot, N., . . . Ferrari, P. (2021). Novel Biomarkers of Habitual Alcohol Intake and Associations With Risk of Pancreatic and Liver Cancers and Liver Disease Mortality. J Natl Cancer Inst. 113(11): 1542-1550. PMID: 34010397  doi: 10.1093/jnci/djab078
  166. Lopez de Maturana, E., Rodriguez, J. A., Alonso, L., Lao, O., Molina-Montes, E., Martin-Antoniano, I. A., . . . Malats, N. (2021). A multilayered post-GWAS assessment on genetic susceptibility to pancreatic cancer. Genome Med. 13(1): 15. PMID: 33517887  doi: 10.1186/s13073-020-00816-4
  167. Martínez-Gregorio, H., Rojas-Jiménez, E., Mejía-Gómez, J. C., Díaz-Velásquez, C., Quezada-Urban, R., Vallejo-Lecuona, F., . . . Vaca-Paniagua, F. (2021). The Evolution of Clinically Aggressive Triple-Negative Breast Cancer Shows a Large Mutational Diversity and Early Metastasis to Lymph Nodes. Cancers (Basel). 13(20). PMID: 34680239  doi: 10.3390/cancers13205091
  168. Middleton, D. R. S., Mmbaga, B. T., O’Donovan, M., Abedi-Ardekani, B., Debiram-Beecham, I., Nyakunga-Maro, G., . . . McCormack, V. (2021). Minimally invasive esophageal sponge cytology sampling is feasible in a Tanzanian community setting. Int J Cancer. 148(5): 1208-1218. PMID: 33128785  doi: 10.1002/ijc.33366
  169. Miranda-Filho, A., Charvat, H., Bray, F., Migowski, A., Cheung, L. C., Vaccarella, S., . . . Robbins, H. A. (2021). A modeling analysis to compare eligibility strategies for lung cancer screening in Brazil. EClinicalMedicine. 42: 101176. PMID: 34765952  doi: 10.1016/j.eclinm.2021.101176
  170. Mocci, E., Kundu, P., Wheeler, W., Arslan, A. A., Beane-Freeman, L. E., Bracci, P. M., . . . Stolzenberg-Solomon, R. (2021). Smoking Modifies Pancreatic Cancer Risk Loci on 2q21.3. Cancer Res. 81(11): 3134-3143. PMID: 33574088  doi: 10.1158/0008-5472.CAN-20-3267
  171. Mohebbi, E., Hadji, M., Rashidian, H., Rezaianzadeh, A., Marzban, M., Haghdoost, A. A., . . . Zendehdel, K. (2021). Opium use and the risk of head and neck squamous cell carcinoma. Int J Cancer. 148(5): 1066-1076. PMID: 32895947  doi: 10.1002/ijc.33289
  172. Moody, S., Senkin, S., Islam, S. M. A., Wang, J., Nasrollahzadeh, D., Cortez Cardoso Penha, R., . . . Stratton, M. R. (2021). Mutational signatures in esophageal squamous cell carcinoma from eight countries with varying incidence. Nat Genet. 53(11): 1553-1563. PMID: 34663923  doi: 10.1038/s41588-021-00928-6
  173. Moore, A., Machiela, M. J., Machado, M., Wang, S. S., Kane, E., Slager, S. L., . . . Berndt, S. I. (2021). Genome-wide homozygosity and risk of four non-Hodgkin lymphoma subtypes. J Transl Genet Genom. 5: 200-217. PMID: 34622145  doi: 10.20517/jtgg.2021.08
  174. Mullins, N., Forstner, A. J., O’Connell, K. S., Coombes, B., Coleman, J. R. I., Qiao, Z., . . . Andreassen, O. A. (2021). Genome-wide association study of more than 40,000 bipolar disorder cases provides new insights into the underlying biology. Nat Genet. 53(6): 817-829. PMID: 34002096  doi: 10.1038/s41588-021-00857-4
  175. Nalini, M., Khoshnia, M., Kamangar, F., Sharafkhah, M., Poustchi, H., Pourshams, A., . . . Etemadi, A. (2021). Joint effect of diabetes and opiate use on all-cause and cause-specific mortality: the Golestan cohort study. Int J Epidemiol. 50(1): 314-324. PMID: 32810213  doi: 10.1093/ije/dyaa126
  176. Nalini, M., Khoshnia, M., Kamangar, F., Sharafkhah, M., Poustchi, H., Pourshams, A., . . . Etemadi, A. (2021). Corrigendum to: Joint effect of diabetes and opiate use on all-cause and cause-specific mortality: the Golestan cohort study. Int J Epidemiol. 50(1): 353. PMID: 33367601  doi: 10.1093/ije/dyaa268
  177. Nasrollahzadeh, D., Roshandel, G., Delhomme, T. M., Avogbe, P. H., Foll, M., Saidi, F., . . . Abedi-Ardekani, B. (2021). TP53 Targeted Deep Sequencing of Cell-Free DNA in Esophageal Squamous Cell Carcinoma Using Low-Quality Serum: Concordance with Tumor Mutation. Int J Mol Sci. 22(11). PMID: 34073316  doi: 10.3390/ijms22115627
  178. Nazarzadeh, M., Bidel, Z., Canoy, D., Copland, E., Wamil, M., Majert, J., . . . Blood Pressure Lowering Treatment Trialists, C. (2021). Blood pressure lowering and risk of new-onset type 2 diabetes: an individual participant data meta-analysis. Lancet. 398(10313): 1803-1810. PMID: 34774144  doi: 10.1016/S0140-6736(21)01920-6
  179. Nost, T. H., Alcala, K., Urbarova, I., Byrne, K. S., Guida, F., Sandanger, T. M., & Johansson, M. (2021). Systemic inflammation markers and cancer incidence in the UK Biobank. Eur J Epidemiol. 36(8): 841-848. PMID: 34036468  doi: 10.1007/s10654-021-00752-6
  180. Pettit, R. W., Byun, J., Han, Y., Ostrom, Q. T., Edelson, J., Walsh, K. M., . . . Amos, C. I. (2021). The shared genetic architecture between epidemiological and behavioral traits with lung cancer. Sci Rep. 11(1): 17559. PMID: 34475455  doi: 10.1038/s41598-021-96685-x
  181. Purdue, M. P., Rhee, J., Moore, L., Gao, X., Sun, X., Kirk, E., . . . Rothman, N. (2021). Differences in risk factors for molecular subtypes of clear cell renal cell carcinoma. Int J Cancer. 149(7): 1448-1454. PMID: 34058014  doi: 10.1002/ijc.33701
  182. Qin, N., Li, Y., Wang, C., Zhu, M., Dai, J., Hong, T., . . . Shen, H. (2021). Comprehensive functional annotation of susceptibility variants identifies genetic heterogeneity between lung adenocarcinoma and squamous cell carcinoma. Front Med. 15(2): 275-291. PMID: 32889700  doi: 10.1007/s11684-020-0779-4
  183. Ramakrishnan, R., Doherty, A., Smith-Byrne, K., Rahimi, K., Bennett, D., Woodward, M., . . . Dwyer, T. (2021). Accelerometer measured physical activity and the incidence of cardiovascular disease: Evidence from the UK Biobank cohort study. PLoS Med. 18(1): e1003487. PMID: 33434193  doi: 10.1371/journal.pmed.1003487
  184. Riscal, R., Bull, C. J., Mesaros, C., Finan, J. M., Carens, M., Ho, E. S., . . . Simon, M. C. (2021). Cholesterol Auxotrophy as a Targetable Vulnerability in Clear Cell Renal Cell Carcinoma. Cancer Discov. 11(12): 3106-3125. PMID: 34244212  doi: 10.1158/2159-8290.CD-21-0211
  185. Robbins, H. A., Alcala, K., Swerdlow, A. J., Schoemaker, M. J., Wareham, N., Travis, R. C., . . . Johansson, M. (2021). Comparative performance of lung cancer risk models to define lung screening eligibility in the United Kingdom. Br J Cancer. 124(12): 2026-2034. PMID: 33846525  doi: 10.1038/s41416-021-01278-0
  186. Rostron, B. L., Wang, J., Etemadi, A., Thakur, S., Chang, J. T., Bhandari, D., . . . Chang, C. M. (2021). Associations between Biomarkers of Exposure and Lung Cancer Risk among Exclusive Cigarette Smokers in the Golestan Cohort Study. Int J Environ Res Public Health. 18(14). PMID: 34299799  doi: 10.3390/ijerph18147349
  187. Saberi Hosnijeh, F., Casabonne, D., Nieters, A., Solans, M., Naudin, S., Ferrari, P., . . . Vermeulen, R. (2021). Association between anthropometry and lifestyle factors and risk of B-cell lymphoma: An exposome-wide analysis. Int J Cancer. 148(9): 2115-2128. PMID: 33128820  doi: 10.1002/ijc.33369
  188. Senkin, S. (2021). MSA: reproducible mutational signature attribution with confidence based on simulations. BMC Bioinformatics. 22(1): 540. PMID: 34736398  doi: 10.1186/s12859-021-04450-8
  189. Seyed Khoei, N., Carreras-Torres, R., Murphy, N., Gunter, M. J., Brennan, P., Smith-Byrne, K., . . . Freisling, H. (2021). Genetically Raised Circulating Bilirubin Levels and Risk of Ten Cancers: A Mendelian Randomization Study. Cells. 10(2). PMID: 33671849  doi: 10.3390/cells10020394
  190. Sheikh, M., Mukeriya, A., Shangina, O., Brennan, P., & Zaridze, D. (2021). Postdiagnosis Smoking Cessation and Reduced Risk for Lung Cancer Progression and Mortality : A Prospective Cohort Study. Ann Intern Med. 174(9): 1232-1239. PMID: 34310171  doi: 10.7326/M21-0252
  191. Sheth, S., Farquhar, D. R., Lenze, N. R., Mazul, A., Brennan, P., Anantharaman, D., . . . Olshan, F. (2021). Decreased overall survival in black patients with HPV-associated oropharyngeal cancer. Am J Otolaryngol. 42(1): 102780. PMID: 33152576  doi: 10.1016/j.amjoto.2020.102780
  192. Simoens, C., Gorbaslieva, I., Gheit, T., Holzinger, D., Lucas, E., Ridder, R., . . . group, H.-A. s. (2021). HPV DNA genotyping, HPV E6*I mRNA detection, and p16(INK4a)/Ki-67 staining in Belgian head and neck cancer patient specimens, collected within the HPV-AHEAD study. Cancer Epidemiol. 72: 101925. PMID: 33839457  doi: 10.1016/j.canep.2021.101925
  193. Singleton, R. K., Heath, A. K., Clasen, J. L., Scelo, G., Johansson, M., Calvez-Kelm, F. L., . . . Muller, D. C. (2021). Risk Prediction for Renal Cell Carcinoma: Results from the European Prospective Investigation into Cancer and Nutrition (EPIC) Prospective Cohort Study. Cancer Epidemiol Biomarkers Prev. 30(3): 507-512. PMID: 33335022  doi: 10.1158/1055-9965.EPI-20-1438
  194. Sklias, A., Halaburkova, A., Vanzan, L., Jimenez, N. F., Cuenin, C., Bouaoun, L., . . . Herceg, Z. (2021). Epigenetic remodelling of enhancers in response to estrogen deprivation and re-stimulation. Nucleic Acids Res. 49(17): 9738-9754. PMID: 34403459  doi: 10.1093/nar/gkab697
  195. Sun, R., Xu, M., Li, X., Gaynor, S., Zhou, H., Li, Z., . . . Lin, X. (2021). Integration of multiomic annotation data to prioritize and characterize inflammation and immune-related risk variants in squamous cell lung cancer. Genet Epidemiol. 45(1): 99-114. PMID: 32924180  doi: 10.1002/gepi.22358
  196. Sun, Y. Q., Richmond, R. C., Suderman, M., Min, J. L., Battram, T., Flatberg, A., . . . Mai, X. M. (2021). Assessing the role of genome-wide DNA methylation between smoking and risk of lung cancer using repeated measurements: the HUNT study. Int J Epidemiol. 50(5): 1482-1497. PMID: 33729499  doi: 10.1093/ije/dyab044
  197. Talukdar, F. R., Soares Lima, S. C., Khoueiry, R., Laskar, R. S., Cuenin, C., Sorroche, B. P., . . . Herceg, Z. (2021). Genome-Wide DNA Methylation Profiling of Esophageal Squamous Cell Carcinoma from Global High-Incidence Regions Identifies Crucial Genes and Potential Cancer Markers. Cancer Res. 81(10): 2612-2624. PMID: 33741694  doi: 10.1158/0008-5472.CAN-20-3445
  198. Viallon, V., His, M., Rinaldi, S., Breeur, M., Gicquiau, A., Hemon, B., . . . Ferrari, P. (2021). A New Pipeline for the Normalization and Pooling of Metabolomics Data. Metabolites. 11(9). PMID: 34564446  doi: 10.3390/metabo11090631
  199. Virani, S., Baiocchi, G., Bowtell, D., Cabasag, C. J., Cho, K. R., Fortner, R. T., . . . Trabert, B. (2021). Joint IARC/NCI International Cancer Seminar Series Report: expert consensus on future directions for ovarian carcinoma research. Carcinogenesis. 42(6): 785-793. PMID: 34037709  doi: 10.1093/carcin/bgab043
  200. Waller, R. G., Klein, R. J., Vijai, J., McKay, J. D., Clay-Gilmour, A., Wei, X., . . . Camp, N. J. (2021). Sequencing at lymphoid neoplasm susceptibility loci maps six myeloma risk genes. Hum Mol Genet. 30(12): 1142-1153. PMID: 33751038  doi: 10.1093/hmg/ddab066
  201. Watts, E. L., Fensom, G. K., Smith Byrne, K., Perez-Cornago, A., Allen, N. E., Knuppel, A., . . . Travis, R. C. (2021). Circulating insulin-like growth factor-I, total and free testosterone concentrations and prostate cancer risk in 200 000 men in UK Biobank. Int J Cancer. 148(9): 2274-2288. PMID: 33252839  doi: 10.1002/ijc.33416
  202. Yano, Y., Abnet, C. C., Poustchi, H., Roshandel, G., Pourshams, A., Islami, F., . . . Etemadi, A. (2021). Oral Health and Risk of Upper Gastrointestinal Cancers in a Large Prospective Study from a High-risk Region: Golestan Cohort Study. Cancer Prev Res (Phila). 14(7): 709-718. PMID: 33731409  doi: 10.1158/1940-6207.Capr-20-0577
  203. Yu, E. Y., Wesselius, A., Mehrkanoon, S., Goosens, M., Brinkman, M., van den Brandt, P., . . . Zeegers, M. P. (2021). Vegetable intake and the risk of bladder cancer in the BLadder Cancer Epidemiology and Nutritional Determinants (BLEND) international study. BMC Med. 19(1): 56. PMID: 33685459  doi: 10.1186/s12916-021-01931-8
  204. Zahed, H., Johansson, M., Ueland, P. M., Midttun, O., Milne, R. L., Giles, G. G., . . . Robbins, H. A. (2021). Epidemiology of 40 blood biomarkers of one-carbon metabolism, vitamin status, inflammation, and renal and endothelial function among cancer-free older adults. Sci Rep. 11(1): 13805. PMID: 34226613  doi: 10.1038/s41598-021-93214-8
  205. Zhou, W., Liu, G., Hung, R. J., Haycock, P. C., Aldrich, M. C., Andrew, A. S., . . . Amos, C. I. (2021). Causal relationships between body mass index, smoking and lung cancer: Univariable and multivariable Mendelian randomization. Int J Cancer. 148(5): 1077-1086. PMID: 32914876  doi: 10.1002/ijc.33292
  206. Abrahao, R., Perdomo, S., Pinto, L. F. R., Nascimento de Carvalho, F., Dias, F. L., de Podesta, J. R. V., . . . Curado, M. P. (2020). Predictors of Survival After Head and Neck Squamous Cell Carcinoma in South America: The InterCHANGE Study. JCO Glob Oncol. 6: 486-499. PMID: 32213095 doi: 10.1200/go.20.00014
  207. Bosse, Y., Li, Z., Xia, J., Manem, V., Carreras-Torres, R., Gabriel, A., . . . McKay, J. D. (2020). Transcriptome-wide association study reveals candidate causal genes for lung cancer. Int J Cancer. 146(7): 1862-1878. PMID: 31696517 doi: 10.1002/ijc.32771
  208. Bray, M. J., Chen, L. S., Fox, L., Hancock, D. B., Culverhouse, R. C., Hartz, S. M., . . . Bierut, L. J. (2020). Dissecting the genetic overlap of smoking behaviors, lung cancer, and chronic obstructive pulmonary disease: A focus on nicotinic receptors and nicotine metabolizing enzyme. Genet Epidemiol. 44(7): 748-758. PMID: 32803792 doi: 10.1002/gepi.22331
  209. Brhane, Y., Yang, P., Christiani, D. C., Liu, G., McLaughlin, J. R., Brennan, P., . . . Hung, R. J. (2020). Genetic Determinants of Lung Cancer Prognosis in Never Smokers: A Pooled Analysis in the International Lung Cancer Consortium. Cancer Epidemiol Biomarkers Prev. 29(10): 1983-1992. PMID: 32699080 doi: 10.1158/1055-9965.Epi-20-0248
  210. Buexm, L. A., Soares-Lima, S. C., Brennan, P., Fernandes, P. V., de Souza Almeida Lopes, M., Nascimento de Carvalho, F., . . . Ribeiro Pinto, L. F. (2020). Hpv impact on oropharyngeal cancer patients treated at the largest cancer center from Brazil. Cancer Lett. 477: 70-75. PMID: 32087309 doi: 10.1016/j.canlet.2020.02.023
  211. Chen, C., Lohavanichbutr, P., Zhang, Y., Houck, J. R., Upton, M. P., Abedi-Ardekani, B., . . . Wang, P. (2020). Prediction of survival of HPV16-negative, p16-negative oral cavity cancer patients using a 13-gene signature: A multicenter study using FFPE samples. Oral Oncol. 100: 104487. PMID: 31835136 doi: 10.1016/j.oraloncology.2019.104487
  212. Christakoudi, S., Kakourou, A., Markozannes, G., Tzoulaki, I., Weiderpass, E., Brennan, P., . . . Tsilidis, K. K. (2020). Blood pressure and risk of cancer in the European Prospective Investigation into Cancer and Nutrition. Int J Cancer. 146(10): 2680-2693. PMID: 31319002 doi: 10.1002/ijc.32576
  213. Clasen, J. L., Heath, A. K., Scelo, G., & Muller, D. C. (2020). Components of one-carbon metabolism and renal cell carcinoma: a systematic review and meta-analysis. Eur J Nutr. 59(8): 3801-3813. PMID: 32162043 doi: 10.1007/s00394-020-02211-6
  214. Cohen, D., Ghosh, S., Shimakawa, Y., Ramou, N., Garcia, P. S., Dubois, A., . . . Chemin, I. (2020). Hepatitis B virus preS2Δ38-55 variants: A newly identified risk factor for hepatocellular carcinoma. JHEP Rep. 2(5): 100144. PMID: 32904132 doi: 10.1016/j.jhepr.2020.100144
  215. Consortium, I. T. P.-C. A. o. W. G. (2020). Pan-cancer analysis of whole genomes. Nature. 578(7793): 82-93. PMID: 32025007 doi: 10.1038/s41586-020-1969-6
  216. Cristiano, S., McKean, D., Carey, J., Bracci, P., Brennan, P., Chou, M., . . . Scharpf, R. B. (2020). Bayesian copy number detection and association in large-scale studies. BMC cancer. 20(1): 856. PMID: 32894098 doi: 10.1186/s12885-020-07304-3
  217. Dagnino, S., Bodinier, B., Grigoryan, H., Rappaport, S. M., Karimi, M., Guida, F., . . . Chadeau-Hyam, M. (2020). Agnostic Cys34-albumin adductomics and DNA methylation: Implication of N-acetylcysteine in lung carcinogenesis years before diagnosis. Int J Cancer. 146(12): 3294-3303. PMID: 31513294 doi: 10.1002/ijc.32680
  218. Dai, J., Huang, M., Amos, C. I., Hung, R. J., Tardon, A., Andrew, A., . . . Shen, H. (2020). Genome-wide association study of INDELs identified four novel susceptibility loci associated with lung cancer risk. Int J Cancer. 146(10): 2855-2864. PMID: 31577861 doi: 10.1002/ijc.32698
  219. de Carvalho, A. C., Perdomo, S., Dos Santos, W., Fernandes, G. C., de Jesus, L. M., Carvalho, R. S., . . . Carvalho, A. L. (2020). Impact of genetic variants in clinical outcome of a cohort of patients with oropharyngeal squamous cell carcinoma. Sci Rep. 10(1): 9970. PMID: 32561788 doi: 10.1038/s41598-020-66741-z
  220. Di Credico, G., Polesel, J., Dal Maso, L., Pauli, F., Torelli, N., Luce, D., . . . Edefonti, V. (2020). Alcohol drinking and head and neck cancer risk: the joint effect of intensity and duration. Br J Cancer. 123(9): 1456-1463. PMID: 32830199 doi: 10.1038/s41416-020-01031-z
  221. Dianatinasab, M., Wesselius, A., Salehi-Abargouei, A., Yu, E. Y. W., Brinkman, M., Fararouei, M., . . . Zeegers, M. P. (2020). Adherence to a Western dietary pattern and risk of bladder cancer: A pooled analysis of 13 cohort studies of the Bladder Cancer Epidemiology and Nutritional Determinants international study. Int J Cancer. 147(12): 3394-3403. PMID: 32580241 doi: 10.1002/ijc.33173
  222. Ecke, T. H., Otto, T., & Le Calvez-Kelm, F. (2020). Evaluating the Utility of Combined Bladder Cancer Biomarkers, the Molecular Prognostication of Tumor Subtypes, or What Else Is Needed to Illuminate Our Vision? International Journal of Molecular Sciences. 21(24): 3. PMID: 33352845 doi: 10.3390/ijms21249657
  223. Etemadi, A., Poustchi, H., Calafat, A. M., Blount, B. C., De Jesus, V. R., Wang, L., . . . Freedman, N. D. (2020). Opiate and Tobacco Use and Exposure to Carcinogens and Toxicants in the Golestan Cohort Study. Cancer Epidemiol Biomarkers Prev. 29(3): 650-658. PMID: 31915141 doi: 10.1158/1055-9965.Epi-19-1212
  224. Farquhar, D. R., Coniglio, A. J., Masood, M. M., Lenze, N., Brennan, P., Anantharaman, D., . . . Hackman, T. G. (2020). Evaluation of pathologic staging using number of nodes in p16-negative head and neck cancer. Oral Oncol. 108: 104800. PMID: 32492516 doi: 10.1016/j.oraloncology.2020.104800
  225. Gabriel, A. A. G., Mathian, E., Mangiante, L., Voegele, C., Cahais, V., Ghantous, A., . . . Foll, M. (2020). A molecular map of lung neuroendocrine neoplasms. Gigascience. 9(11). PMID: 33124659 doi: 10.1093/gigascience/giaa112
  226. Galateau Salle, F., Le Stang, N., Tirode, F., Courtiol, P., Nicholson, A. G., Tsao, M. S., . . . Girard, N. (2020). Comprehensive Molecular and Pathologic Evaluation of Transitional Mesothelioma Assisted by Deep Learning Approach: A Multi-Institutional Study of the International Mesothelioma Panel from the MESOPATH Reference Center. J Thorac Oncol. 15(6): 1037-1053. PMID: 32165206 doi: 10.1016/j.jtho.2020.01.025
  227. Galimberti, M., Leuenberger, C., Wolf, B., Szilágyi, S. M., Foll, M., & Wegmann, D. (2020). Detecting Selection from Linked Sites Using an F-Model. Genetics. 216(4): 1205-1215. PMID: 33067324 doi: 10.1534/genetics.120.303780
  228. Ghoneim, D. H., Zhu, J., Zheng, W., Long, J., Murff, H. J., Ye, F., . . . Wu, L. (2020). Mendelian Randomization Analysis of n-6 Polyunsaturated Fatty Acid Levels and Pancreatic Cancer Risk. Cancer Epidemiol Biomarkers Prev. 29(12): 2735-2739. PMID: 32967863 doi: 10.1158/1055-9965.Epi-20-0651
  229. Gormley, M., Dudding, T., Sanderson, E., Martin, R. M., Thomas, S., Tyrrell, J., . . . Richmond, R. C. (2020). A multivariable Mendelian randomization analysis investigating smoking and alcohol consumption in oral and oropharyngeal cancer. Nat Commun. 11(1): 6071. PMID: 33247085 doi: 10.1038/s41467-020-19822-6
  230. Gupta, P., Shahzad, N., Harold, A., Shuda, M., Venuti, A., Romero-Medina, M. C., . . . Tommasino, M. (2020). Merkel Cell Polyomavirus Downregulates N-myc Downstream-Regulated Gene 1, Leading to Cellular Proliferation and Migration. J Virol. 94(3): e00899-00819. PMID: 31694959 doi: 10.1128/jvi.00899-19
  231. Hall, A. L., Kromhout, H., Schuz, J., Peters, S., Portengen, L., Vermeulen, R., . . . Olsson, A. (2020). Laryngeal Cancer Risks in Workers Exposed to Lung Carcinogens: Exposure-Effect Analyses Using a Quantitative Job Exposure Matrix. Epidemiology. 31(1): 145-154. PMID: 31577634 doi: 10.1097/ede.0000000000001120
  232. Hariri, S., Sharafi, H., Sheikh, M., Merat, S., Hashemi, F., Azimian, F., . . . Malekzadeh, R. (2020). Continuum of hepatitis C care cascade in prison and following release in the direct-acting antivirals era. Harm Reduct J. 17(1): 80. PMID: 33081794 doi: 10.1186/s12954-020-00431-x
  233. Hejazi, J., Ghanavati, M., Hejazi, E., Poustchi, H., Sepanlou, S. G., Khoshnia, M., . . . Hekmatdoost, A. (2020). Habitual dietary intake of flavonoids and all-cause and cause-specific mortality: Golestan cohort study. Nutr J. 19(1): 108. PMID: 32988395 doi: 10.1186/s12937-020-00627-8
  234. Hornigold, N., Dunn, K. R., Craven, R. A., Zougman, A., Trainor, S., Shreeve, R., . . . Vasudev, N. S. (2020). Dysregulation at multiple points of the kynurenine pathway is a ubiquitous feature of renal cancer: implications for tumour immune evasion. Br J Cancer. 123(1): 137-147. PMID: 32390008 doi: 10.1038/s41416-020-0874-y
  235. Hosen, M. I., Forey, N., Durand, G., Voegele, C., Bilici, S., Avogbe, P. H., . . . Zvereva, M. (2020). Development of Sensitive Droplet Digital PCR Assays for Detecting Urinary TERT Promoter Mutations as Non-Invasive Biomarkers for Detection of Urothelial Cancer. Cancers (Basel). 12(12): 3541. PMID: 33260905 doi: 10.3390/cancers12123541
  236. Hosen, M. I., Sheikh, M., Zvereva, M., Scelo, G., Forey, N., Durand, G., . . . Calvez-Kelm, F. L. (2020). Urinary TERT promoter mutations are detectable up to 10 years prior to clinical diagnosis of bladder cancer: Evidence from the Golestan Cohort Study. EBioMedicine. 53: 102643. PMID: 32081602 doi: 10.1016/j.ebiom.2020.102643
  237. Howe, L. J., Hemani, G., Lesseur, C., Gaborieau, V., Ludwig, K. U., Mangold, E., . . . Lewis, S. J. (2020). Evaluating shared genetic influences on nonsyndromic cleft lip/palate and oropharyngeal neoplasms. Genet Epidemiol. 44(8): 924-933. PMID: 32710482 doi: 10.1002/gepi.22343
  238. Huang, J. Y., Larose, T. L., Luu, H. N., Wang, R., Fanidi, A., Alcala, K., . . . Yuan, J. M. (2020). Circulating markers of cellular immune activation in prediagnostic blood sample and lung cancer risk in the Lung Cancer Cohort Consortium (LC3). Int J Cancer. 146(9): 2394-2405. PMID: 31276202 doi: 10.1002/ijc.32555
  239. Islami, F., Poustchi, H., Pourshams, A., Khoshnia, M., Gharavi, A., Kamangar, F., . . . Malekzadeh, R. (2020). A prospective study of tea drinking temperature and risk of esophageal squamous cell carcinoma. Int J Cancer. 146(1): 18-25. PMID: 30891750 doi: 10.1002/ijc.32220
  240. Ji, X., Mukherjee, S., Landi, M. T., Bosse, Y., Joubert, P., Zhu, D., . . . Amos, C. I. (2020). Protein-altering germline mutations implicate novel genes related to lung cancer development. Nat Commun. 11(1): 2220. PMID: 32393777 doi: 10.1038/s41467-020-15905-6
  241. Kachuri, L., Graff, R. E., Smith-Byrne, K., Meyers, T. J., Rashkin, S. R., Ziv, E., . . . Johansson, M. (2020). Pan-cancer analysis demonstrates that integrating polygenic risk scores with modifiable risk factors improves risk prediction. Nat Commun. 11(1): 6084. PMID: 33247094 doi: 10.1038/s41467-020-19600-4
  242. Kachuri, L., Johansson, M., Rashkin, S. R., Graff, R. E., Bosse, Y., Manem, V., . . . Hung, R. J. (2020). Immune-mediated genetic pathways resulting in pulmonary function impairment increase lung cancer susceptibility. Nat Commun. 11(1): 27. PMID: 31911640 doi: 10.1038/s41467-019-13855-2
  243. Kleinstern, G., Camp, N. J., Berndt, S. I., Birmann, B. M., Nieters, A., Bracci, P. M., . . . Cerhan, J. R. (2020). Lipid Trait Variants and the Risk of Non-Hodgkin Lymphoma Subtypes: A Mendelian Randomization Study. Cancer Epidemiol Biomarkers Prev. 29(5): 1074-1078. PMID: 32108027 doi: 10.1158/1055-9965.EPI-19-0803
  244. Kleinstern, G., Yan, H., Hildebrandt, M. A. T., Vijai, J., Berndt, S. I., Ghesquieres, H., . . . Cerhan, J. R. (2020). Inherited variants at 3q13.33 and 3p24.1 are associated with risk of diffuse large B-cell lymphoma and implicate immune pathways. Hum Mol Genet. 29(1): 70-79. PMID: 31600786 doi: 10.1093/hmg/ddz228
  245. Knuppel, A., Fensom, G. K., Watts, E. L., Gunter, M. J., Murphy, N., Papier, K., . . . Key, T. J. (2020). Circulating Insulin-like Growth Factor-I Concentrations and Risk of 30 Cancers: Prospective Analyses in UK Biobank. Cancer Res. 80(18): 4014-4021. PMID: 32709735 doi: 10.1158/0008-5472.Can-20-1281
  246. Kreimer, A. R., Chaturvedi, A. K., Alemany, L., Anantharaman, D., Bray, F., Carrington, M., . . . Brennan, P. (2020). Summary from an international cancer seminar focused on human papillomavirus (HPV)-positive oropharynx cancer, convened by scientists at IARC and NCI. Oral Oncol. 108: 104736. PMID: 32502860 doi: 10.1016/j.oraloncology.2020.104736
  247. Lantuejoul, S., Fernandez-Cuesta, L., Damiola, F., Girard, N., & McLeer, A. (2020). New molecular classification of large cell neuroendocrine carcinoma and small cell lung carcinoma with potential therapeutic impacts. Translational Lung Cancer Research. 9(5): 2233-2244. PMID: 33209646 doi: 10.21037/tlcr-20-269
  248. Larose, T. L., Meheus, F., Brennan, P., Johansson, M., & Robbins, H. A. (2020). Assessment of Biomarker Testing for Lung Cancer Screening Eligibility. JAMA Netw Open. 3(3): e200409. PMID: 32134462 doi: 10.1001/jamanetworkopen.2020.0409
  249. Lebrett, M. B., Balata, H., Evison, M., Colligan, D., Duerden, R., Elton, P., . . . Crosbie, P. A. J. (2020). Analysis of lung cancer risk model (PLCOM2012 and LLPv2) performance in a community-based lung cancer screening programme. Thorax. 75(8): 661-668. PMID: 32631933 doi: 10.1136/thoraxjnl-2020-214626
  250. McCormack, V., McKenzie, F., Foerster, M., Zietsman, A., Galukande, M., Adisa, C., . . . Dos-Santos-Silva, I. (2020). Breast cancer survival and survival gap apportionment in sub-Saharan Africa (ABC-DO): a prospective cohort study. Lancet Glob Health. 8(9): e1203-e1212. PMID: 32827482 doi: 10.1016/S2214-109X(20)30261-8
  251. Montealegre-Paez, A. L., Pacheco-Orozco, R., Martinez-Gregorio, H., Vaca-Paniagua, F., Ardila, J., Cayol, F., . . . Perdomo, S. (2020). Liquid biopsy in the diagnosis and monitoring of cancer patients: opportunities and challenges in Latin America. Revista Colombiana de Cancerología. 24(4): 164-177. doi: 10.35509/01239015.44
  252. Murphy, N., Knuppel, A., Papadimitriou, N., Martin, R. M., Tsilidis, K. K., Smith-Byrne, K., . . . Gunter, M. J. (2020). Insulin-like growth factor-1, insulin-like growth factor-binding protein-3, and breast cancer risk: observational and Mendelian randomization analyses with approximately 430 000 women. Ann Oncol. 31(5): 641-649. PMID: 32169310 doi: 10.1016/j.annonc.2020.01.066
  253. Nalini, M., Shakeri, R., Poustchi, H., Pourshams, A., Etemadi, A., Islami, F., . . . Malekzadeh, R. (2020). Long-term opiate use and risk of cardiovascular mortality: results from the Golestan Cohort Study. Eur J Prev Cardiol. PMID: 33624066 doi: 10.1093/eurjpc/zwaa006
  254. Naudin, S., Solans Margalef, M., Saberi Hosnijeh, F., Nieters, A., Kyro, C., Tjonneland, A., . . . Ferrari, P. (2020). Healthy lifestyle and the risk of lymphoma in the European Prospective Investigation into Cancer and Nutrition study. Int J Cancer. 147(6): 1649-1656. PMID: 32176325 doi: 10.1002/ijc.32977
  255. Naudin, S., Viallon, V., Hashim, D., Freisling, H., Jenab, M., Weiderpass, E., . . . Ferrari, P. (2020). Healthy lifestyle and the risk of pancreatic cancer in the EPIC study. Eur J Epidemiol. 35(10): 975-986. PMID: 31564045 doi: 10.1007/s10654-019-00559-6
  256. Nicholson, A. G., Sauter, J. L., Nowak, A. K., Kindler, H. L., Gill, R. R., Remy-Jardin, M., . . . Galateau-Salle, F. (2020). EURACAN/IASLC Proposals for Updating the Histologic Classification of Pleural Mesothelioma: Towards a More Multidisciplinary Approach. J Thorac Oncol. 15(1): 29-49. PMID: 31546041 doi: 10.1016/j.jtho.2019.08.2506
  257. Pacheco-Orozco, R. A., Montealegre-Paez, L., Cayol, F., Martinez-Gregorio, H., Oliver, J., Frecha, C., . . . Perdomo, S. (2020). AR-V7 as a Biomarker for Resistance to Treatment with Abiraterone/Enzalutamide in Three Latin American Countries: A Hypothetical Cost-Saving Analysis. Oncologist. 25(12): e1990-e1995. PMID: 32721059 doi: 10.1634/theoncologist.2020-0043
  258. Pasqual, E., Turner, M. C., Gracia-Lavedan, E., Casabonne, D., Benavente, Y., Chef, I. T., . . . de Sanjose, S. (2020). Association of ionizing radiation dose from common medical diagnostic procedures and lymphoma risk in the Epilymph case-control study. PLoS ONE. 15(7): e0235658. PMID: 32649712 doi: 10.1371/journal.pone.0235658
  259. Purdue, M. P., Song, L., Scelo, G., Houlston, R. S., Wu, X., Sakoda, L. C., . . . Yu, K. (2020). Pathway Analysis of Renal Cell Carcinoma Genome-Wide Association Studies Identifies Novel Associations. Cancer Epidemiol Biomarkers Prev. 29(10): 2065-2069. PMID: 32732251 doi: 10.1158/1055-9965.EPI-20-0472
  260. Rojas-Jimenez, E., Mejia-Gomez, J. C., Diaz-Velasquez, C., Quezada-Urban, R., Martinez Gregorio, H., Vallejo-Lecuona, F., . . . Vaca-Paniagua, F. (2020). Comprehensive Genomic Profile of Heterogeneous Long Follow-Up Triple-Negative Breast Cancer and Its Clinical Characteristics Shows DNA Repair Deficiency Has Better Prognostic. Genes (Basel). 11(11): 21. PMID: 33227964 doi: 10.3390/genes11111367
  261. Rosato, V., Negri, E., Bosetti, C., Malats, N., Gomez-Rubio, P., Consortium, P., . . . La Vecchia, C. (2020). Gallbladder disease, cholecystectomy, and pancreatic cancer risk in the International Pancreatic Cancer Case-Control Consortium (PanC4). Eur J Cancer Prev. 29(5): 408-415. PMID: 32740166 doi: 10.1097/cej.0000000000000572
  262. Saberi Hosnijeh, F., Kolijn, P. M., Casabonne, D., Nieters, A., Solans, M., Naudin, S., . . . Vermeulen, R. (2020). Mediating effect of soluble B-cell activation immune markers on the association between anthropometric and lifestyle factors and lymphoma development. Sci Rep. 10(1): 13814. PMID: 32796953 doi: 10.1038/s41598-020-70790-9
  263. Saraiya, V., Bradshaw, P., Meyer, K., Gammon, M., Slade, G., Brennan, P., . . . Olshan, A. (2020). The association between diet quality and cancer incidence of the head and neck. Cancer Causes Control. 31(2): 193-202. PMID: 31894494 doi: 10.1007/s10552-019-01261-4
  264. Sheikh, M., Kamangar, F., & Malekzadeh, R. (2020). Fifty Years of Research and One Conclusion: Opium Causes Cancer. Arch Iran Med. 23(11): 757-760. PMID: 33220692 doi: 10.34172/aim.2020.95
  265. Sheikh, M., Masoudi, S., Bakhshandeh, R., Moayyedkazemi, A., Zamani, F., Nikfam, S., . . . Pourshams, A. (2020). Survival features, prognostic factors, and determinants of diagnosis and treatment among Iranian patients with pancreatic cancer, a prospective study. PLoS ONE. 15(12): e0243511. PMID: 33275621 doi: 10.1371/journal.pone.0243511
  266. Sheikh, M., Poustchi, H., Pourshams, A., Khoshnia, M., Gharavi, A., Zahedi, M., . . . Malekzadeh, R. (2020). Household Fuel Use and the Risk of Gastrointestinal Cancers: The Golestan Cohort Study. Environ Health Perspect. 128(6): 67002. PMID: 32609005 doi: 10.1289/ehp5907
  267. Sheikh, M., Shakeri, R., Poustchi, H., Pourshams, A., Etemadi, A., Islami, F., . . . Malekzadeh, R. (2020). Opium use and subsequent incidence of cancer: results from the Golestan Cohort Study. Lancet Glob Health. 8(5): e649-e660. PMID: 32353313 doi: 10.1016/S2214-109X(20)30059-0
  268. Singleton, R. K., Heath, A. K., Clasen, J. L., Scelo, G., Johansson, M., Calvez-Kelm, F. L., . . . Muller, D. C. (2020). Risk Prediction for Renal Cell Carcinoma: Results from the European Prospective Investigation into Cancer and Nutrition (EPIC) Prospective Cohort Study. Cancer Epidemiol Biomarkers Prev. 30(3): 507-512. PMID: 33335022 doi: 10.1158/1055-9965.EPI-20-1438
  269. Tagliabue, M., Mena, M., Maffini, F., Gheit, T., Quirós Blasco, B., Holzinger, D., . . . The Hpv-Ahead Study, G. (2020). Role of Human Papillomavirus Infection in Head and Neck Cancer in Italy: The HPV-AHEAD Study. Cancers (Basel). 12(12): 3567. PMID: 33260360 doi: 10.3390/cancers12123567
  270. Tang, H., Jiang, L., Stolzenberg-Solomon, R. Z., Arslan, A. A., Beane Freeman, L. E., Bracci, P. M., . . . Wei, P. (2020). Genome-Wide Gene-Diabetes and Gene-Obesity Interaction Scan in 8,255 Cases and 11,900 Controls from PanScan and PanC4 Consortia. Cancer Epidemiol Biomarkers Prev. 29(9): 1784-1791. PMID: 32546605 doi: 10.1158/1055-9965.Epi-20-0275
  271. Thomas, C. E., Wang, R., Adams-Haduch, J., Murphy, S. E., Ueland, P. M., Midttun, O., . . . Yuan, J. M. (2020). Urinary Cotinine Is as Good a Biomarker as Serum Cotinine for Cigarette Smoking Exposure and Lung Cancer Risk Prediction. Cancer Epidemiol Biomarkers Prev. 29(1): 127-132. PMID: 31685561 doi: 10.1158/1055-9965.Epi-19-0653
  272. Wang, Y., Gorlova, O. Y., Gorlov, I. P., Zhu, M., Dai, J., Albanes, D., . . . Shen, H. (2020). Association Analysis of Driver Gene-Related Genetic Variants Identified Novel Lung Cancer Susceptibility Loci with 20,871 Lung Cancer Cases and 15,971 Controls. Cancer Epidemiol Biomarkers Prev. 29(7): 1423-1429. PMID: 32277007 doi: 10.1158/1055-9965.EPI-19-1085
  273. Waterboer, T., Brenner, N., Klussmann, J. P., Brennan, P., Wieland, U., & Robbins, H. A. (2020). Study results and related evidence do not support use of HPV16 L1 DRH1 antibodies as a cancer screening test. EBioMedicine. 62: 103143. PMID: 33249381 doi: 10.1016/j.ebiom.2020.103143
  274. Yang, J. J., Yu, D., Xiang, Y. B., Blot, W., White, E., Robien, K., . . . Shu, X. O. (2020). Association of Dietary Fiber and Yogurt Consumption With Lung Cancer Risk: A Pooled Analysis. JAMA Oncol. 6(2): e194107. PMID: 31647500 doi: 10.1001/jamaoncol.2019.4107
  275. Yang, T., Tang, H., Risch, H. A., Olson, S. H., Peterson, G., Bracci, P. M., . . . Wei, P. (2020). Incorporating multiple sets of eQTL weights into gene-by-environment interaction analysis identifies novel susceptibility loci for pancreatic cancer. Genet Epidemiol. 44(8): 880-892. PMID: 32779232 doi: 10.1002/gepi.22348
  276. Yu, E. Y. W., Wesselius, A., Mehrkanoon, S., Brinkman, M., van den Brandt, P., White, E., . . . Zeegers, M. P. (2020). Grain and dietary fiber intake and bladder cancer risk: a pooled analysis of prospective cohort studies. Am J Clin Nutr. 112(5): 1252-1266. PMID: 32778880 doi: 10.1093/ajcn/nqaa215
  277. Yuan, F., Hung, R. J., Walsh, N., Zhang, H., Platz, E. A., Wheeler, W., . . . Stolzenberg-Solomon, R. (2020). Genome-Wide Association Study Data Reveal Genetic Susceptibility to Chronic Inflammatory Intestinal Diseases and Pancreatic Ductal Adenocarcinoma Risk. Cancer Res. 80(18): 4004-4013. PMID: 32641412 doi: 10.1158/0008-5472.Can-20-0447
  278. Zhang, Y. D., Hurson, A. N., Zhang, H., Choudhury, P. P., Easton, D. F., Milne, R. L., . . . Garcia-Closas, M. (2020). Assessment of polygenic architecture and risk prediction based on common variants across fourteen cancers. Nat Commun. 11(1): 3353. PMID: 32620889 doi: 10.1038/s41467-020-16483-3
  279. Zhong, J., Jermusyk, A., Wu, L., Hoskins, J. W., Collins, I., Mocci, E., . . . Amundadottir, L. T. (2020). A Transcriptome-Wide Association Study Identifies Novel Candidate Susceptibility Genes for Pancreatic Cancer. J Natl Cancer Inst. 112(10): 1003-1012. PMID: 31917448 doi: 10.1093/jnci/djz246
  280. Zhu, J., Shu, X., Guo, X., Liu, D., Bao, J., Milne, R. L., . . . Wu, L. (2020). Associations between Genetically Predicted Blood Protein Biomarkers and Pancreatic Cancer Risk. Cancer Epidemiol Biomarkers Prev. 29(7): 1501-1508. PMID: 32439797 doi: 10.1158/1055-9965.EPI-20-0091
  281. Zvereva, M., Pisarev, E., Hosen, I., Kisil, O., Matskeplishvili, S., Kubareva, E., . . . Calvez-Kelm, F. L. (2020). Activating Telomerase TERT Promoter Mutations and Their Application for the Detection of Bladder Cancer. Int J Mol Sci. 21(17): 18. PMID: 32839402 doi: 10.3390/ijms21176034
  282. Zvereva, M., Roberti, G., Durand, G., Voegele, C., Nguyen, M. D., Delhomme, T. M., . . . Le Calvez-Kelm, F. (2020). Circulating tumour-derived KRAS mutations in pancreatic cancer cases are predominantly carried by very short fragments of cell-free DNA. EBioMedicine. 55: 102462. PMID: 32249202 doi: 10.1016/j.ebiom.2019.09.042

 

 

 

 

Close Reading Mode
UP